0001965040-24-000064 | 10-Q | XBRL Viewer

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

9 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

Summary of Derivative Instruments

The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative instruments such as foreign currency forward contracts and interest rate swap agreements. The Company does not hold or issue derivative instruments for trading purposes. The derivative instrument contracts are with major investment grade financial institutions and the Company does not anticipate any material non-performance by any of the counterparties. The Company does not believe that its exposure to market risk is material to the Company’s financial position or results of operations.

The fair value of the Company’s interest rate swaps and foreign currency forward contracts are determined based on observable market inputs (Level 2). The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:


		Fair Value of Derivatives At
		September 30, 2024				December 31, 2023
	Balance Sheet Classification	Asset		Liability		Asset		Liability
Derivatives designated as hedging instruments:
Interest rate swaps	Accrued expenses and other	$	0.1	$	(0.7)	$	—	$	—
	Other liabilities	—		(2.2)		0.7		(2.6)
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other	$	1.5	$	—	$	0.8	$	—
	Other current liabilities	—		(0.2)		—		—

The notional amounts of the Company’s interest rate swaps and foreign currency forward contracts were $150.0 and $502.0 as of September 30, 2024 and $150.0 and $458.3 as of December 31, 2023, respectively.

The following table presents the pre-tax effects of cash flow hedges included in the Company’s condensed consolidated and combined statements of comprehensive income (loss):


	Pre-Tax Gain (Loss) Included in Other Comprehensive Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Interest rate swaps	$	(2.9)	$	—	$	0.4	$	—

The following table presents amounts reclassified out of accumulated other comprehensive loss and recognized in condensed consolidated and combined statements of operations:


		Amounts Reclassified from Other Comprehensive Loss into Earnings
		Three Months Ended September 30,				Nine Months Ended September 30,
	Statement of Operations Classification	2024		2023		2024		2023
Deferred gain (loss) reclassified into earnings	Interest expense	$	(0.4)	$	—	$	(1.2)	$	—

The estimated amount of pre-tax net losses included in other comprehensive loss that is expected to be reclassified into earnings over the twelve months following September 30, 2024, is $0.6.

Refer to Note 9 - Preferred Stock and Common Shareholders' Equity for the impact of the Company’s derivative instruments included in accumulated other comprehensive loss.

The following table presents a summary of the loss for derivative contracts not designated as hedges included in the Company’s condensed consolidated and combined statements of operations:


		Gain (Loss) on Derivatives Recognized in Earnings
		Three Months Ended September 30,				Nine Months Ended September 30,
	Statement of Operations Classification	2024		2023		2024		2023
Foreign currency forward contracts	Foreign exchange gain (loss)	$	1.0	$	—	$	0.6	$	—

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Interest rate swaps \| Derivatives designated as hedging instruments: \| Accrued expenses and other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Asset	$ 0.1	$ 0.0
Liability	(0.7)	0.0
Interest rate swaps \| Derivatives designated as hedging instruments: \| Other current liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Asset	0.0	0.7
Liability	(2.2)	(2.6)
Foreign currency forward contracts \| Derivatives not designated as hedging instruments: \| Prepaid expenses and other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Asset	1.5	0.8
Liability	0.0	0.0
Foreign currency forward contracts \| Derivatives not designated as hedging instruments: \| Other current liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Asset	0.0	0.0
Liability	$ (0.2)	$ 0.0

PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY - Narrative (Details) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Equity [Abstract]
Common stock, shares authorized (in shares)	265,000,000.0
Common stock, par value per share (in dollars per share)	$ 0.001
Preferred stock, shares authorized (in shares)	30,000,000.0
Preferred stock, par value per share (in dollars per share)	$ 0.001
Preferred stock, shares outstanding (in shares)	0	0

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (27.9)	$ (138.4)	$ (101.0)	$ (14.0)	$ 30.8	$ 12.5	$ (267.3)	$ 29.3
Foreign currency translation adjustments	73.4			(55.6)			38.0	(6.6)
Net benefit plan adjustments	0.0			0.0			0.0	2.1
Unrealized gain (loss) on derivative instruments	(3.3)			1.6			(0.8)	1.6
Other comprehensive income (loss) before tax	70.1			(54.0)			37.2	(2.9)
Provision (benefit) for income tax related to items of comprehensive income	0.8			(0.4)			0.2	(0.4)
Other comprehensive income (loss), net of tax	70.9	$ (7.4)	$ (26.1)	(54.4)	$ 32.0	$ 19.1	37.4	(3.3)
Comprehensive income (loss)	$ 43.0			$ (68.4)			$ (229.9)	$ 26.0

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

- Definition

Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.

+ References + Details

SUPPLEMENTAL CASH FLOW INFORMATION

9 Months Ended

Sep. 30, 2024

Supplemental Cash Flow Elements [Abstract]

SUPPLEMENTAL CASH FLOW INFORMATION


	Nine Months Ended September 30,
	2024		2023
Supplemental schedule of cash flow information:
Cash paid during period for:
Interest	$	98.3	$	22.9
Income taxes, net of refunds	56.8		21.9
Disclosure of non-cash investing activities:
Change in accrued property, plant and equipment	(0.5)		(1.5)
Fair value of contingent consideration related to the sale of assets	39.6		—
Disclosure of non-cash transfers to (from) Parent:
Change in right-of-use lease assets	—		13.9
Change in property, plant and equipment, net	—		(27.7)

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Pre-tax loss expected to be reclassified	$ 0.6
Interest rate swaps \| Derivatives designated as hedging instruments:
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	150.0	$ 150.0
Foreign currency forward contracts \| Derivatives not designated as hedging instruments:
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	$ 502.0	$ 458.3

TRANSACTIONS WITH FORMER PARENT (Tables)

9 Months Ended

Sep. 30, 2024

Schedule of Related Party Transactions

The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023:



	Three Months Ended September 30, 2023		Nine Months Ended September 30, 2023
Direct costs	$	—	$	86.6
Selling, general and administrative expenses	—		105.0
Restructuring and other charges	—		0.2
Foreign exchange gain (loss)	—		2.2
Corporate and other allocations	$	—	$	194.0

The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 were as follows:


	Three Months Ended September 30, 2023		Nine Months Ended September 30, 2023
Special Payment to Former Parent	$	—	$	(1,595.0)
General financing activities	—		(286.8)
Corporate allocations	—		184.9
Stock compensation expense	—		10.2
Total net transfers (to) from Former Parent	$	—	$	(1,686.7)

SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash paid during period for:
Interest	$ 98.3	$ 22.9
Income taxes, net of refunds	56.8	21.9
Disclosure of non-cash investing and financing activities
Change in accrued property, plant and equipment	(0.5)	(1.5)
Fair value of contingent consideration related to the sale of assets	39.6	0.0
Disclosure of non-cash transfers to (from) Parent:
Change in right-of-use lease assets	0.0	13.9
Change in property, plant and equipment, net	$ 0.0	$ (27.7)

STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 13.0	$ 10.4	$ 41.9	$ 25.5
Income tax benefits	2.1	1.7	6.4	4.4
Direct costs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	11.2	6.6	32.5	15.4
Selling, general and administrative expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 1.8	$ 3.8	$ 9.4	$ 10.1

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES For the three months ended September 30, 2024 and 2023, the Company recognized income tax benefits of $17.3 and $5.8, respectively, which resulted in effective tax rates of 48.3% and 26.5%, respectively. The effective tax rate for the three months ended September 30, 2024 was higher than the Company’s statutory tax rate primarily due to the geographic mix of earnings, partially offset by a forecasted valuation allowance on the deferred tax asset for the carryforward of disallowed interest expense, which impacts the annualized effective tax rate of the Company by approximately 14.8%. This deferred tax asset exists due to limitations imposed under the Internal Revenue Code on the annual deductibility of business interest expense. The effective tax rate for the three months ended September 30, 2023 was higher than the Company’s statutory tax rate primarily due to the geographic mix of earnings partially offset by U.S. taxes on foreign earnings. For the nine months ended September 30, 2024, the Company recognized an income tax benefit of $2.5 resulting in an effective tax rate of 1.2%. For the nine months ended September 30, 2023, the Company recognized income tax expense of $7.3 resulting in an effective tax rate of 30.2% for the nine months ended September 30, 2023. The effective tax rate for the nine months ended September 30, 2024 was lower than the Company’s statutory tax rate primarily due to the valuation allowance recognized on the deferred tax asset for the carryforward of disallowed interest expense and non-deductible compensation expenses. The effective tax rate for the nine months ended September 30, 2023 was higher than the Company’s statutory tax rate primarily due to the geographic mix of earnings partially offset by U.S. taxes on foreign earnings. During the nine months ended September 30, 2024, the amount of net unrecognized tax positions increased by less than $0.1. Management believes it is unlikely that the unrecognized income tax benefits and interest will decrease during the next 12 months.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

DISCONTINUED OPERATIONS - Schedule of Selected Information on Cash Flows Related to Discontinued Operations (Details) - Discontinued operations, disposed of by sale - Enabling Services segment disposal - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	$ 0.0		$ 2.2	$ 1.6	$ 6.5
Goodwill impairment				24.0	0.0
Loss on sale of business	$ 0.0	$ 23.2	$ 0.0	23.2	0.0
Capital expenditures				$ 7.4	$ 12.0

TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Related Party Transaction [Line Items]
Corporate and other allocations	$ 0.0	$ 194.0
Direct costs
Related Party Transaction [Line Items]
Corporate and other allocations	0.0	86.6
Selling, general and administrative expenses
Related Party Transaction [Line Items]
Corporate and other allocations	0.0	105.0
Restructuring and other charges
Related Party Transaction [Line Items]
Corporate and other allocations	0.0	0.2
Foreign exchange gain (loss)
Related Party Transaction [Line Items]
Corporate and other allocations	$ 0.0	$ 2.2

DEBT

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

DEBT

In connection with the Spin, Fortrea incurred indebtedness in an aggregate principal amount of approximately $1,640.0, which consisted of borrowings under senior secured term loan facilities and senior secured notes. Fortrea also entered into a $450.0 senior secured revolving credit facility. Fortrea used the proceeds from

these debt transactions to make a cash distribution to Labcorp as consideration for the assets that were contributed to the Company in connection with the Spin.

The current portion of long-term debt at September 30, 2024 and December 31, 2023 consisted of the following:


	September 30, 2024		December 31, 2023
Current portion of senior secured term loan A facility due 2028	$	—	$	25.0
Current portion of senior secured term loan B facility due 2030	—		5.7

Debt issuance discount and fees	—		(4.6)
Total short-term borrowings and current portion of long-term debt	$	—	$	26.1

Long-term debt at September 30, 2024 and December 31, 2023 consisted of the following:


	September 30, 2024		December 31, 2023
7.5% senior notes due 2030	$	570.0	$	570.0
Senior secured term loan A due 2028	417.3		462.5
Senior secured term loan B due 2030	154.7		561.5
Debt issuance discount and fees	(17.5)		(28.1)
Total long-term debt	$	1,124.5	$	1,565.9

During the three and nine months ended September 30, 2024, the Company paid down $0.0 and $70.2, respectively, on our senior secured term loan A due 2028 (“term loan A”) and $0.0 and $412.5, respectively, on our senior secured term loan B due 2030 (“term loan B”). Additionally, in the second quarter of 2024, the Company wrote off $12.2 of unamortized debt issuance costs associated with the pay down of debt, which were recorded in Interest expense in the condensed consolidated and combined statements of operations during the nine months ended September 30, 2024.

Senior Notes

On June 27, 2023, the Company issued $570.0 aggregate principal amount of 7.50% senior notes due 2030 (the “Notes”). Interest on these notes is payable semi-annually on January 1 and July 1 of each year. Net proceeds from the offering of the Notes were $560.2 after deducting expenses of the offering.

Credit Facilities

On June 30, 2023, Fortrea entered into a credit agreement (as amended, the “Credit Agreement”) providing for (i) a senior secured revolving credit facility in the principal amount of up to $450.0; (ii) a five-year $500.0 first lien senior secured term A loan facility; and (iii) a seven-year $570.0 first lien senior secured term B loan facility. The initial revolving facility includes a $75.0 swingline sub-facility and a $75.0 letter of credit sub-facility.

The Company drew on the term A and term B loans on June 30, 2023. The net proceeds received for the term A and term B loans were $491.8 and $552.9, respectively after deducting underwriting discounts and other expenses. The term A and term B loans will mature on June 30, 2028 and June 30, 2030, respectively. The term loans accrue interest at a per annum rate equal to the sum of, at the option of the Company, a Base Rate or a Term SOFR Rate and the Applicable Margin as defined by the Credit Agreement. As of September 30, 2024, the effective interest rate on the term A loan and term B loan was 6.82% and 8.49%, respectively.

The revolving credit facility is permitted, subject to certain covenant restrictions, to be used for general corporate purposes, including working capital and capital expenditures. There were no balances outstanding on the Company’s current revolving credit facility as of September 30, 2024, and $450.0 was available for borrowing as of September 30, 2024. No balances were outstanding as of December 31, 2023. As of September 30, 2024, the effective interest rate on the revolving credit facility was 6.82%, assuming one-month interest election. There is a commitment fee associated with the revolving credit facility of 0.35% (per annum and paid quarterly) and an annual $0.1 agency fee (paid in quarterly installments). The credit facility matures on June 30, 2028.

Under the Credit Agreement, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for similarly rated borrowers, and the Company is required to maintain certain net leverage and interest coverage ratios. The Company is permitted to make adjustments, such as excluding certain costs, from the calculation of leverage and interest coverage ratios for compliance purposes. On May 3, 2024, the Company entered into an amendment to modify certain financial covenants for additional flexibility under the Credit Agreement. The Company was in compliance with all covenants in the Credit Agreement at September 30, 2024 and believes it will be in compliance with all covenants for a period of at least 12 months from the date these financial statements are issued.

There were no outstanding letters of credit under the Credit Agreement as of September 30, 2024.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

DEBT - Schedule of Debt (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Jun. 27, 2023
Current Portion of Long-Term Debt
Debt issuance discount and fees	$ 0.0	$ (4.6)
Total short-term borrowings and current portion of long-term debt	0.0	26.1
Long-Term Debt
Debt issuance discount and fees	(17.5)	(28.1)
Total long-term debt	1,124.5	1,565.9
Line of credit \| Secured debt \| Senior secured term loan A due 2028
Current Portion of Long-Term Debt
Current portion of debt, gross	0.0	25.0
Long-Term Debt
Debt, gross	417.3	462.5
Line of credit \| Secured debt \| Senior secured term loan B due 2030
Current Portion of Long-Term Debt
Current portion of debt, gross	0.0	5.7
Long-Term Debt
Debt, gross	$ 154.7	561.5
Senior notes \| 7.5% senior notes due 2030
Long-Term Debt
Stated interest rate	7.50%		7.50%
Debt, gross	$ 570.0	$ 570.0

DEBT (Tables)

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Schedule of Debt

The current portion of long-term debt at September 30, 2024 and December 31, 2023 consisted of the following:


	September 30, 2024		December 31, 2023
Current portion of senior secured term loan A facility due 2028	$	—	$	25.0
Current portion of senior secured term loan B facility due 2030	—		5.7

Debt issuance discount and fees	—		(4.6)
Total short-term borrowings and current portion of long-term debt	$	—	$	26.1

Long-term debt at September 30, 2024 and December 31, 2023 consisted of the following:


	September 30, 2024		December 31, 2023
7.5% senior notes due 2030	$	570.0	$	570.0
Senior secured term loan A due 2028	417.3		462.5
Senior secured term loan B due 2030	154.7		561.5
Debt issuance discount and fees	(17.5)		(28.1)
Total long-term debt	$	1,124.5	$	1,565.9

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

+ Details

REVENUES (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Segment and Geography

The Company’s revenues by geography for the three and nine months ended September 30, 2024 and 2023 are as follows:


	Three Months Ended September 30, 2024								Three Months Ended September 30, 2023
	North America		Europe		Other		Total		North America		Europe		Other		Total
Revenues	$	319.7	$	191.8	$	163.4	$	674.9	$	349.5	$	204.3	$	160.0	$	713.8


	Nine Months Ended September 30, 2024								Nine Months Ended September 30, 2023
	North America		Europe		Other		Total		North America		Europe		Other		Total
Revenues	$	944.4	$	595.1	$	459.9	$	1,999.4	$	1,073.6	$	600.7	$	458.5	$	2,132.8

Schedule of Capitalized Contract Cost

The following table provides information about contract asset balances:


	September 30, 2024		December 31, 2023
Sales commission assets	$	20.6	$	15.8
Deferred contract costs	1.4		2.0
Total	$	22.0	$	17.8

Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue

The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:


	September 30, 2024		December 31, 2023
Accounts receivable	$	156.2	$	420.2
Unbilled services	569.9		600.0
Less: allowance for credit losses	(37.0)		(31.7)
Total	$	689.1	$	988.5

Unearned revenue	$	321.1	$	214.2

Schedule of Rollforward of Allowance for Credit Losses

The rollforward for the allowance for credit losses for the nine months ended September 30, 2024 is as follows:


	Accounts Receivable
Allowance for credit losses as of December, 2023	$	31.7
Credit loss expense	17.0
Write-offs	(11.6)
Foreign currency impact	(0.1)
Allowance for credit losses as of September 30, 2024	$	37.0

BASIS OF FINANCIAL STATEMENT PRESENTATION	9 Months Ended
BASIS OF FINANCIAL STATEMENT PRESENTATION	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF FINANCIAL STATEMENT PRESENTATION	BASIS OF FINANCIAL STATEMENT PRESENTATION Description of Business Fortrea Holdings Inc. (“Fortrea” or the “Company”), a Delaware corporation incorporated on January 31, 2023, is a leading global contract research organization (“CRO”) providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers highly flexible delivery models that include Full Service, Functional Service Provider, and Hybrid Service structures. The Company has a rich history of providing clinical development services for over 30 years across more than 20 therapeutic areas, first as Covance and later as Labcorp Drug Development. On June 30, 2023, the Company completed a spin-off (the “Spin” or the “Separation”) from Laboratory Corporation of America Holdings (“Labcorp” or “Former Parent”). The Company leverages its global scale, clinical data insights, scientific expertise, technology innovation, industry network and decades of experience as a standalone company and as a business unit prior to the Spin to deliver tailored solutions to its customers. With what the Company believes is a distinctive market offering, Fortrea meets growing global demand for clinical development services. The Company manages its business in one reportable segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has established access to all key markets worldwide through a strategic footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide. Reportable Segment On March 9, 2024, the Company, together with its wholly-owned subsidiary, Fortrea Inc., entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Endeavor Buyer LLC, an affiliate of Arsenal Capital Partners, to sell the operations of Fortrea Patient Access Inc. and its subsidiaries and Endpoint Clinical, Inc. and its subsidiaries; which are all collectively referred to as the Enabling Services Segment. Refer to Note 2 - Discontinued Operations for further discussion. For all periods presented, the Company's consolidated revenues from continuing operations were generated from the Clinical Services segment, which provides phase I-IV clinical trials, including clinical pharmacology and comprehensive clinical development capabilities. The Company’s chief operating decision maker allocates resources and assesses performance for the Clinical Services segment. Discontinued Operations In accordance with the definition of discontinued operations, the Company's decision to sell the assets relating to the Enabling Services Segment represented a strategic shift that had a major effect on the Company's results of operations and assets and liabilities for the periods presented. As a result, the Company has classified the assets and liabilities related to the Enabling Services Segment as assets of discontinued operations and liabilities of discontinued operations on the condensed consolidated balance sheet as of December 31, 2023. The operations of the Enabling Services Segment have been classified as income (loss) from discontinued operations on the condensed consolidated and combined statements of operations for all periods presented. Unless otherwise noted, discussion within these notes to the condensed consolidated and combined financial statements relates to the Company’s continuing operations. Agreements with Labcorp On June 30, 2023, the Company completed the Spin from Labcorp. The Company has entered into several agreements with Labcorp that govern the relationship of the parties following the Separation, including the Separation and Distribution Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and the Transition Services Agreement with Labcorp, which are described in the Company’s Registration Statement on Form 10, as amended (“Form 10”), as filed with the Securities and Exchange Commission (the “SEC”). Under the terms of the Transition Services Agreement, the Company and Labcorp agreed to provide each other certain transitional services. The services and assets to be provided to Fortrea by Labcorp support the Company’s enterprise functions, most notably IT applications, network and security support and hosting, as well as finance, human resources, marketing and other administrative support. Basis of Financial Statement Presentation Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company, and reflect Labcorp’s net investment in the Company. The condensed consolidated financial statements subsequent to June 30, 2023 reflect the results of operations, cash flows, and financial position of Fortrea as a standalone company, whereas all prior periods included consolidated and combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.” The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year, and additionally, condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The condensed consolidated and combined statements of operations include all revenues and costs directly attributable to Fortrea’s business. The combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation. These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or another reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented and may not be representative of future expenses that may be incurred. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp. As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent. All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin. Refer to Note 12 - Transactions with Former Parent for further information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services. The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions. Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2024, one customer accounted for 15.6% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2023, two pharmaceutical companies accounted for approximately 17.0% and 11.2% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months ended September 30, 2024, one customer accounted for approximately 15.1% of revenues, and for the nine months ended September 30, 2024, two customers accounted for approximately 14.2% and 10.4% of revenues. For the three months ended September 30, 2023, two customer accounted for 14.6% and 11.4% of revenues, and for the nine months ended September 30, 2023, two customer accounted for 11.1% and 10.6% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts. Reclassification Certain previously reported amounts have been reclassified to conform to the current year presentation. During the quarter ended March 31, 2024, a change in basis of presentation, to include information technology costs and certain facility costs in Selling, general and administrative expenses was made to improve comparability of costs against peer companies in the clinical research industry. As a result, the Company reclassified $39.0 and $117.3 from Direct costs, exclusive of depreciation and amortization, to Selling, general and administrative expenses, exclusive of depreciation and amortization in the condensed consolidated and combined statement of operations for the three and nine months ended September 30, 2023, respectively, relating to information technology costs and certain facility charges. There is no impact on total operating expenses, operating income or net income during the period ended September 30, 2023. Direct costs include payroll and related benefits for project-related employees, pass through costs, facility costs related to phase I clinics and other direct costs from the Transition Services Agreement with Labcorp. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, information technology costs, other facility charges, advertising and promotional expenses, administrative travel and credit loss provisions. Additionally, the Company reclassified $0.1 from Other, net to Interest expense in the condensed consolidated and combined statement of operations for the nine months ended September 30, 2023. Restatement of Prior Period Financial Statements In connection with the preparation of the Company’s financial statements for the quarter ended March 31, 2024, the Company identified errors impacting previously reported financial information, including to periods prior to the June 30, 2023 Spin. The errors consisted primarily of a goodwill impairment charge as a result of an incorrect carrying value used in the Company’s impairment calculation, a reduction in revenue due to the misstatement in the amount of the ultimate resolution of a customer matter, an understatement of expense accruals allocated from Former Parent prior to spin, and an understatement of depreciation expense associated with certain projects that were not depreciated in a timely manner. Management assessed the materiality of the errors, including the presentation of prior period consolidated financial statements, on a qualitative and quantitative basis in accordance with SEC Staff Accounting Bulletin No. 99, Materiality, codified in Accounting Standards Codification (“ASC”) Topic 250, Accounting Changes and Error Corrections. Based on this assessment, the Company concluded that these errors and the related impacts did not result in a material misstatement of the previously issued consolidated and combined financial statements as of and for the fiscal years ended December 31, 2022 and 2023, and the previously issued unaudited condensed consolidated and combined interim financial statements for the quarters ended March 31, June 30, and September 30, 2023. However, correcting the cumulative effect of these errors in the first quarter of 2024 would have had a significant effect on the results of operations for that period. Therefore, the relevant prior periods’ financial statements and related footnotes, for these and other immaterial errors for comparative purposes, have been corrected. Previously reported financial information for such immaterial errors will continue to be corrected in future filings, as applicable. A summary of the corrections to the impacted financial statement line items from the previously issued financial statements are presented in Note 14 - Immaterial Financial Restatement and Reclassifications to Prior Period Financial Statements. Recently Issued and Adopted Accounting Standards In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to improve reportable segment disclosure requirements. The new guidance requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included in the reported measure of segment profit or loss. It does not change the definition of a segment or the guidance for determining reportable segments. The new guidance will be effective for the Company in the annual period beginning January 1, 2024 and in 2025 for interim periods. The Company does not expect the adoption of this standard to have a material impact on its results of operations, financial position or cash flows. In December 2023, the FASB issued guidance to require qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

REVENUES - Narrative (Details) - USD ($)			3 Months Ended		9 Months Ended
REVENUES - Narrative (Details) - USD ($)	May 06, 2024	Jun. 28, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	May 31, 2024	Jun. 23, 2023
Capitalized Contract Cost [Line Items]
Unearned revenue, revenue recognized					$ 147,600,000	$ 162,600,000
Accounts receivable sold		$ 17,500,000	$ 300,000,000.0
Remaining performance obligation			4,491,000,000		4,491,000,000
Performance obligation partially satisfied in previous period, revenue recognized			6,000,000	$ 16,000,000	58,000,000	48,000,000
Revenue reduction			(674,900,000)	(713,800,000)	(1,999,400,000)	(2,132,800,000)
Increase in loss from continuing operations			$ 35,800,000	$ 21,900,000	$ 200,100,000	$ (24,200,000)
Basic earnings (loss) per share (in dollars per share)			$ (0.31)	$ (0.16)	$ (2.99)	$ 0.33
ARPP, maximum facility amount								$ 80,000,000.0
Proceeds from sale of receivables		$ 17,300,000	$ 297,900,000
Factored customer receivables							$ 0
Receivables securitization program, term	3 years
Receivables securitization program, amount	$ 300,000,000.0
Receivables securitization program, fees associated with sale			5,300,000		$ 7,400,000
Change in scope and change in estimated effort to complete contract
Capitalized Contract Cost [Line Items]
Revenue reduction			4,000,000	$ 5,000,000	25,000,000	$ 21,000,000
Increase in loss from continuing operations			$ 2,000,000	$ 4,000,000	$ 25,000,000	$ 14,000,000
Basic earnings (loss) per share (in dollars per share)			$ (0.02)	$ (0.05)	$ (0.28)	$ (0.16)
Minimum
Capitalized Contract Cost [Line Items]
Remaining performance obligation, period			1 year		1 year
Maximum
Capitalized Contract Cost [Line Items]
Remaining performance obligation, period			8 years		8 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Capitalized Contract Cost [Line Items]
Remaining performance obligation, percentage			27.00%		27.00%
Remaining performance obligation, period			12 months		12 months
Sales commission assets
Capitalized Contract Cost [Line Items]
Capitalized assets, amortization			$ 2,900,000	$ 2,000,000.0	$ 8,500,000	$ 9,400,000
Deferred contract costs
Capitalized Contract Cost [Line Items]
Capitalized assets, amortization			$ 600,000	$ 500,000	$ 1,500,000	$ 1,600,000

PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,461.1	$ 1,591.9	$ 1,714.1	$ 1,747.8	$ 3,402.8	$ 3,340.0
Current year adjustments, before reclassifications						19.1
Amounts reclassified from other accumulated income (loss)	(0.4)	(0.4)	(0.4)
Tax effect of adjustments	0.8	(0.1)	(0.5)	(0.4)	0.0	0.0
Ending balance	1,513.5	1,461.1	1,591.9	1,690.5	1,747.8	3,402.8
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(249.0)	(241.6)	(215.5)	(223.7)	(255.7)	(274.8)
Ending balance	(178.1)	(249.0)	(241.6)	(278.1)	(223.7)	(255.7)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(242.1)	(234.4)	(206.7)	(217.0)	(246.9)	(266.0)
Current year adjustments, before reclassifications	73.4	(7.7)	(27.7)	(55.6)	29.9	19.1
Tax effect of adjustments					0.0	0.0
Ending balance	(168.7)	(242.1)	(234.4)	(272.6)	(217.0)	(246.9)
Net Benefit Plan Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(7.4)	(7.4)	(7.4)	(6.7)	(8.8)	(8.8)
Current year adjustments, before reclassifications					2.1
Tax effect of adjustments					0.0	0.0
Ending balance	(7.4)	(7.4)	(7.4)	(6.7)	(6.7)	(8.8)
Unrealized Gain (Loss) on Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0.5	0.2	(1.4)	0.0	0.0	0.0
Current year adjustments, before reclassifications	(2.9)	0.8	2.5	1.6
Amounts reclassified from other accumulated income (loss)	(0.4)	(0.4)	(0.4)
Tax effect of adjustments	0.8	(0.1)	(0.5)	(0.4)	0.0	0.0
Ending balance	$ (2.0)	$ 0.5	$ 0.2	$ 1.2	$ 0.0	$ 0.0

- Definition

Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2

+ Details

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)

9 Months Ended

Sep. 30, 2024

Supplemental Cash Flow Elements [Abstract]

Schedule of Supplemental Cash Flow Information


	Nine Months Ended September 30,
	2024		2023
Supplemental schedule of cash flow information:
Cash paid during period for:
Interest	$	98.3	$	22.9
Income taxes, net of refunds	56.8		21.9
Disclosure of non-cash investing activities:
Change in accrued property, plant and equipment	(0.5)		(1.5)
Fair value of contingent consideration related to the sale of assets	39.6		—
Disclosure of non-cash transfers to (from) Parent:
Change in right-of-use lease assets	—		13.9
Change in property, plant and equipment, net	—		(27.7)

REVENUES - Schedule of Revenue by Segment and Geography (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 674.9	$ 713.8	$ 1,999.4	$ 2,132.8
North America
Disaggregation of Revenue [Line Items]
Revenues	319.7	349.5	944.4	1,073.6
Europe
Disaggregation of Revenue [Line Items]
Revenues	191.8	204.3	595.1	600.7
Other
Disaggregation of Revenue [Line Items]
Revenues	$ 163.4	$ 160.0	$ 459.9	$ 458.5

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

RESTRUCTURING AND OTHER CHARGES (Tables)

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Other Charges

The following represents the Company’s restructuring accrual activities for the periods indicated:


	Severance and Other Employee Costs		Facility Costs		Total
Balance as of December 31, 2023	$	1.1	$	3.2	$	4.3
Restructuring charges	16.0		0.7		16.7
Reduction of prior restructuring accruals	(0.9)		(3.0)		(3.9)
Cash payments and other adjustments	(14.2)		(0.6)		(14.8)
Balance as of September 30, 2024	$	2.0	$	0.3	$	2.3


	Severance and Other Employee Costs		Facility Costs		Total
Balance as of December 31, 2022	$	1.8	$	4.5	$	6.3
Restructuring charges	9.7		0.9		10.6

Cash payments and other adjustments	(8.4)		(1.2)		(9.6)
Balance as of September 30, 2023	$	3.1	$	4.2	$	7.3

RESTRUCTURING AND OTHER CHARGES

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

RESTRUCTURING AND OTHER CHARGES

During 2023, the Company took actions to reduce overcapacity, align resources, and restructure certain operations. These actions included eliminating redundant positions and aligning resources and facilities for cost improvements and to meet customer requirements. These restructuring actions are expected to continue throughout 2024.

The following represents the Company’s restructuring accrual activities for the periods indicated:


	Severance and Other Employee Costs		Facility Costs		Total
Balance as of December 31, 2023	$	1.1	$	3.2	$	4.3
Restructuring charges	16.0		0.7		16.7
Reduction of prior restructuring accruals	(0.9)		(3.0)		(3.9)
Cash payments and other adjustments	(14.2)		(0.6)		(14.8)
Balance as of September 30, 2024	$	2.0	$	0.3	$	2.3


	Severance and Other Employee Costs		Facility Costs		Total
Balance as of December 31, 2022	$	1.8	$	4.5	$	6.3
Restructuring charges	9.7		0.9		10.6

Cash payments and other adjustments	(8.4)		(1.2)		(9.6)
Balance as of September 30, 2023	$	3.1	$	4.2	$	7.3

The current portion of the restructuring liabilities is included in the condensed consolidated balance sheets in accrued expenses and other current liabilities. The non-current portion of the restructuring liabilities is included in the condensed consolidated balance sheets in other liabilities.

The non-current portion of restructuring liabilities as of September 30, 2024 and December 31, 2023, was $0.0 and $2.4, respectively.

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:


		Fair Value of Derivatives At
		September 30, 2024				December 31, 2023
	Balance Sheet Classification	Asset		Liability		Asset		Liability
Derivatives designated as hedging instruments:
Interest rate swaps	Accrued expenses and other	$	0.1	$	(0.7)	$	—	$	—
	Other liabilities	—		(2.2)		0.7		(2.6)
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other	$	1.5	$	—	$	0.8	$	—
	Other current liabilities	—		(0.2)		—		—

The following table presents the pre-tax effects of cash flow hedges included in the Company’s condensed consolidated and combined statements of comprehensive income (loss):


	Pre-Tax Gain (Loss) Included in Other Comprehensive Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Interest rate swaps	$	(2.9)	$	—	$	0.4	$	—

The following table presents amounts reclassified out of accumulated other comprehensive loss and recognized in condensed consolidated and combined statements of operations:


		Amounts Reclassified from Other Comprehensive Loss into Earnings
		Three Months Ended September 30,				Nine Months Ended September 30,
	Statement of Operations Classification	2024		2023		2024		2023
Deferred gain (loss) reclassified into earnings	Interest expense	$	(0.4)	$	—	$	(1.2)	$	—

The following table presents a summary of the loss for derivative contracts not designated as hedges included in the Company’s condensed consolidated and combined statements of operations:


		Gain (Loss) on Derivatives Recognized in Earnings
		Three Months Ended September 30,				Nine Months Ended September 30,
	Statement of Operations Classification	2024		2023		2024		2023
Foreign currency forward contracts	Foreign exchange gain (loss)	$	1.0	$	—	$	0.6	$	—

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References + Details

RESTRUCTURING AND OTHER CHARGES - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring reserve, non current	$ 0.0	$ 2.4

COMMITMENTS AND CONTINGENT LIABILITIES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Loss contingency accrual	$ 12.5		$ 12.5
Loss contingency, provision	$ 0.9	$ 8.7	$ 3.0

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS

9 Months Ended

Sep. 30, 2024

Accounting Changes and Error Corrections [Abstract]

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS

As discussed in Note 1 - Basis of Financial Statement Presentation the Company identified errors in the consolidated and combined financial statements of prior periods during the first quarter of 2024. A summary of the corrections to the impacted financial statement line items in the previously issued Consolidated Balance Sheet as of December 31, 2023, and the Consolidated and Combined Statements of Operations, Comprehensive Income, Changes in Stockholders’ Equity, and Cash Flows as of and for the years ended December 31, 2023 and 2022, included in the previously filed Annual Report on Form 10-K, was provided in the previously filed Quarterly Report on Form 10-Q for the three months ended March 31, 2024.

A summary of the corrections to the impacted financial statement line items in the Company’s previously issued Condensed Consolidated and Combined Statements of Operations, Comprehensive Income, Changes in Stockholders’ Equity, and Cash Flows for the three and nine month periods ended September 30, 2023 and Consolidated Balance Sheet as of December 31, 2023, which were previously filed in 2023, are also provided below.

CONSOLIDATED BALANCE SHEET


	As of December 31, 2023
	As Previously Reported		Adjustments		As Restated		Discontinued Operations Reclassifications		As Restated and Reclassified
ASSETS
Current assets:
Cash and cash equivalents	$	108.6	$	—	$	108.6	$	—	$	108.6
Accounts receivable and unbilled services, net	1,052.1		(3.2)		1,048.9		(60.4)		988.5
Prepaid expenses and other	92.4		0.9		93.3		(8.7)		84.6
Current assets held for sale from discontinued operations	—		—		—		69.1		69.1
Total current assets	1,253.1		(2.3)		1,250.8		—		1,250.8
Property, plant and equipment, net	220.9		(7.7)		213.2		(40.6)		172.6
Goodwill, net	2,029.3		(13.4)		2,015.9		(276.5)		1,739.4
Intangible assets, net	771.2		—		771.2		(43.1)		728.1
Deferred income taxes	3.2		—		3.2		—		3.2
Other assets, net	79.5		(1.2)		78.3		(8.6)		69.7
Long-term assets held for sale from discontinued operations	—		—		—		368.8		368.8
Total assets	$	4,357.2	$	(24.6)	$	4,332.6	$	—	$	4,332.6
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	132.8	$	4.6	$	137.4	$	(4.5)	$	132.9
Accrued expenses and other current liabilities	356.1		(3.3)		352.8		(17.3)		335.5
Unearned revenue	241.4		1.2		242.6		(28.4)		214.2
Current portion of long-term debt	26.1		—		26.1		—		26.1
Short-term operating lease liabilities	19.5		—		19.5		(2.3)		17.2
Current liabilities held for sale from discontinued operations	—		—		—		52.5		52.5
Total current liabilities	775.9		2.5		778.4		—		778.4
Long-term debt, less current portion	1,565.9		—		1,565.9		—		1,565.9
Operating lease liabilities	66.5		—		66.5		(3.7)		62.8
Deferred income taxes and other tax liabilities	148.8		(1.1)		147.7		—		147.7
Other liabilities	61.3		(1.3)		60.0		(27.9)		32.1
Long-term liabilities held for sale from discontinued operations	—		—		—		31.6		31.6
Total liabilities	2,618.4		0.1		2,618.5		—		2,618.5
Commitments and contingent liabilities
Equity
Former parent investment	—		—		—		—		—
Common stock	0.1		—		0.1		—		0.1
Additional paid-in capital	2,006.2		(8.2)		1,998.0		—		1,998.0
Accumulated deficit	(49.1)		(19.4)		(68.5)		—		(68.5)
Accumulated other comprehensive loss	(218.4)		2.9		(215.5)		—		(215.5)
Total equity	1,738.8		(24.7)		1,714.1		—		1,714.1
Total liabilities and equity	$	4,357.2	$	(24.6)	$	4,332.6	$	—	$	4,332.6

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS


	Three Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated		Discontinued Operations Reclassifications		Change in Basis of Presentation		As Restated and Reclassified
Revenues	$	776.4	$	0.8	$	777.2	$	(63.4)	$	—	$	713.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	647.3		1.4		648.7		(44.8)		(40.1)		563.8
Selling, general and administrative expenses, exclusive of depreciation and amortization	78.9		(0.1)		78.8		(12.1)		40.1		106.8
Depreciation and amortization	24.6		0.4		25.0		(2.2)		—		22.8

Restructuring and other charges	11.6		—		11.6		(1.5)		—		10.1
Total costs and expenses	762.4		1.7		764.1		(60.6)		—		703.5
Operating income (loss)	14.0		(0.9)		13.1		(2.8)		—		10.3
Other income (expense):
Interest expense	(34.6)		—		(34.6)		—		—		(34.6)
Foreign exchange gain (loss)	(0.9)		(0.2)		(1.1)		(0.1)		—		(1.2)
Other, net	3.6		—		3.6		—		—		3.6
Income (loss) before income taxes	(17.9)		(1.1)		(19.0)		(2.9)		—		(21.9)
Income tax (benefit) expense	(4.8)		(0.2)		(5.0)		(0.8)		—		(5.8)
Net loss	$	(13.1)	$	(0.9)	$	(14.0)	$	(2.1)	$	—	$	(16.1)



Earnings (loss) per common share:
Basic - continuing operations	$	(0.15)			$	(0.16)					$	(0.18)
Basic - discontinued operations	—				—						0.02
Basic	$	(0.15)			$	(0.16)					$	(0.16)

Diluted - continuing operations	$	(0.15)			$	(0.16)					$	(0.18)
Diluted - discontinued operations	—				—						0.02
Diluted	$	(0.15)			$	(0.16)					$	(0.16)

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF OPERATIONS


	Nine Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated		Discontinued Operations Reclassifications		Change in Basis of Presentation		As Restated and Reclassified
Revenues	$	2,333.6	$	(2.8)	$	2,330.8	$	(198.0)	$	—	$	2,132.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	1,932.9		0.2		1,933.1		(135.2)		(123.9)		1,674.0
Selling, general and administrative expenses, exclusive of depreciation and amortization	237.7		(0.3)		237.4		(39.9)		123.9		321.4
Depreciation and amortization	72.5		1.1		73.6		(6.5)		—		67.1

Restructuring and other charges	16.7		—		16.7		(2.4)		—		14.3
Total costs and expenses	2,259.8		1.0		2,260.8		(184.0)		—		2,076.8
Operating income (loss)	73.8		(3.8)		70.0		(14.0)		—		56.0
Other income (expense):
Interest expense	(35.3)		—		(35.3)		—		0.1		(35.2)
Foreign exchange gain (loss)	(1.0)		(0.4)		(1.4)		0.2		—		(1.2)
Other, net	4.6		—		4.6		0.1		(0.1)		4.6
Income (loss) before income taxes	42.1		(4.2)		37.9		(13.7)		—		24.2
Income tax (benefit) expense	9.5		(0.9)		8.6		(1.3)		—		7.3
Net income	$	32.6	$	(3.3)	$	29.3	$	(12.4)	$	—	$	16.9



Earnings per common share:
Basic - continuing operations	$	0.37			$	0.33					$	0.19
Basic - discontinued operations	—				—						0.14
Basic	$	0.37			$	0.33					$	0.33

Diluted - continuing operations	$	0.37			$	0.33					$	0.19
Diluted - discontinued operations	—				—						0.14
Diluted	$	0.37			$	0.33					$	0.33

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)


	Three Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated
Net loss	$	(13.1)	$	(0.9)	$	(14.0)
Foreign currency translation adjustments	(56.0)		0.4		(55.6)

Unrealized gain on derivative instruments	1.6		—		1.6
Other comprehensive loss, before tax	(54.4)		0.4		(54.0)
Income tax expense related to items of comprehensive loss	(0.4)		—		(0.4)
Other comprehensive loss, net of tax	(54.8)		0.4		(54.4)
Comprehensive loss	$	(67.9)	$	(0.5)	$	(68.4)

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF COMPREHENSIVE INCOME (LOSS)


	Nine Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated
Net income	$	32.6	$	(3.3)	$	29.3
Foreign currency translation adjustments	(7.6)		1.0		(6.6)
Net benefit plan adjustments	2.1		—		2.1
Unrealized gain on derivative instruments	1.6		—		1.6
Other comprehensive loss, before tax	(3.9)		1.0		(2.9)
Income tax expense related to items of comprehensive loss	(0.4)		—		(0.4)
Other comprehensive loss, net of tax	(4.3)		1.0		(3.3)
Comprehensive income	$	28.3	$	(2.3)	$	26.0

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF CHANGES IN EQUITY


	Common Stock
	Shares	Amounts		Additional Paid-in Capital		Former Parent Investment		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Equity
Previously reported
Balance at December 31, 2022	—	$	—	$	—	$	3,618.6	$	—	$	(276.0)	$	3,342.6
Net income	—	—		—		17.4		—		—		17.4
Other comprehensive income, net of tax	—	—		—		—		—		18.9		18.9
Net transfers from Former Parent	—	—		—		26.6		—		—		26.6
Balance at March 31, 2023	—	—		—		3,662.6		—		(257.1)		3,405.5
Net income	—	—		—		28.3		—		—		28.3
Other comprehensive income, net of tax	—	—		—		—		—		31.6		31.6
Special payment to Former Parent	—	—		—		(1,595.0)		—		—		(1,595.0)
Net transfers to Former Parent	—	—		—		(119.4)		—		—		(119.4)
Reclassification of Former Parent investment to additional paid-in capital	—	—		1,976.5		(1,976.5)		—		—		—
Issuance of common stock	88.8	0.1		—		—		—		—		0.1
Balance at June 30, 2023	88.8	0.1		1,976.5		—		—		(225.5)		1,751.1
Net loss	—	—		—		—		(13.1)		—		(13.1)
Other comprehensive loss, net of tax	—	—		—		—		—		(54.8)		(54.8)
Stock compensation	—	—		11.1		—		—		—		11.1
Balance at September 30, 2023	88.8	$	0.1	$	1,987.6	$	—	$	(13.1)	$	(280.3)	$	1,694.3
Adjustments
Balance at December 31, 2022	—	$	—	$	—	$	(3.8)	$	—	$	1.2	$	(2.6)
Net income	—	—		—		(4.9)		—		—		(4.9)
Other comprehensive income, net of tax	—	—		—		—		—		0.2		0.2
Net transfers from Former Parent	—	—		—		4.6		—		—		4.6
Balance at March 31, 2023	—	—		—		(4.1)		—		1.4		(2.7)
Net income	—	—		—		2.5		—		—		2.5
Other comprehensive income, net of tax	—	—		—		—		—		0.4		0.4

Net transfers to Former Parent	—	—		—		(3.5)		—		—		(3.5)
Reclassification of Former Parent investment to additional paid-in capital	—	—		(5.1)		5.1		—		—		—

Balance at June 30, 2023	—	—		(5.1)		—		—		1.8		(3.3)
Net loss	—	—		—		—		(0.9)		—		(0.9)
Other comprehensive loss, net of tax	—	—		—		—		—		0.4		0.4

Balance at September 30, 2023	—	$	—	$	(5.1)	$	—	$	(0.9)	$	2.2	$	(3.8)


	Common Stock
	Shares	Amounts		Additional Paid-in Capital		Former Parent Investment		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Equity

















As Restated
Balance at December 31, 2022	—	$	—	$	—	$	3,614.8	$	—	$	(274.8)	$	3,340.0
Net income	—	—		—		12.5		—		—		12.5
Other comprehensive income, net of tax	—	—		—		—		—		19.1		19.1
Net transfers from Former Parent	—	—		—		31.2		—		—		31.2
Balance at March 31, 2023	—	—		—		3,658.5		—		(255.7)		3,402.8
Net income	—	—		—		30.8		—		—		30.8
Other comprehensive income, net of tax	—	—		—		—		—		32.0		32.0
Special payment to Former Parent	—	—		—		(1,595.0)		—		—		(1,595.0)
Net transfers to Former Parent	—	—		—		(122.9)		—		—		(122.9)
Reclassification of Former Parent investment to additional paid-in capital	—	—		1,971.4		(1,971.4)		—		—		—
Issuance of common stock	88.8	0.1		—		—		—		—		0.1
Balance at June 30, 2023	88.8	0.1		1,971.4		—		—		(223.7)		1,747.8
Net loss	—	—		—		—		(14.0)		—		(14.0)
Other comprehensive loss, net of tax	—	—		—		—		—		(54.4)		(54.4)
Stock compensation	—	—		11.1		—		—		—		11.1
Balance at September 30, 2023	88.8	$	0.1	$	1,982.5	$	—	$	(14.0)	$	(278.1)	$	1,690.5

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF CASH FLOWS


	Nine Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	32.6	$	(3.3)	$	29.3
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	72.5		1.1		73.6
Stock compensation	27.2		—		27.2
Operating lease right-of-use asset expense	20.9		—		20.9
Goodwill and other asset impairments	—		—		—
Deferred income taxes	(12.7)		(0.6)		(13.3)
Other, net	3.5		—		3.5
Change in assets and liabilities (net of effects of acquisitions):
Increase in accounts receivable and unbilled services, net	(26.6)		3.5		(23.1)
Decrease in prepaid expenses and other	(3.1)		3.7		0.6
Increase in accounts payable	47.3		(1.4)		45.9
Decrease in deferred revenue	(6.5)		0.5		(6.0)
Decrease in accrued expenses and other	(0.1)		(8.5)		(8.6)
Net cash provided by operating activities	155.0		(5.0)		150.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(30.9)		—		(30.9)
Proceeds from sale of assets	8.1		—		8.1
Net cash used for investing activities	(22.8)		—		(22.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities	24.0		—		24.0
Payments on revolving credit facilities	(24.0)		—		(24.0)
Proceeds from term loans	1,061.4		—		1,061.4
Proceeds from issuance of senior notes	570.0		—		570.0
Debt issuance costs	(26.4)		—		(26.4)
Principal payments of long-term debt	(7.7)		—		(7.7)
Special payment to Former Parent	(1,595.0)		—		(1,595.0)
Net transfers from Parent	(136.7)		1.3		(135.4)
Net cash used for financing activities	(134.4)		1.3		(133.1)
Effect of exchange rate changes on cash and cash equivalents	(2.3)		1.6		(0.7)
Net change in cash and cash equivalents	(4.5)		(2.1)		(6.6)
Cash and cash equivalents at beginning of period	112.0		(1.6)		110.4
Cash and cash equivalents at end of period	$	107.5	$	(3.7)	$	103.8

The cash flows related to discontinued operations have not been segregated and are included in the adjusted and restated statements of cash flows included above.

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - shares shares in Millions	Sep. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Statement of Financial Position [Abstract]
Common stock, outstanding (in shares)	89.7	88.8	88.8

EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Employee stock options and awards (in shares)	89.6	88.8	89.4	89.0
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Employee stock options and awards (in shares)	2.8	0.5	2.0	1.5
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0.5	0.4	0.9	0.0

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 674.9	$ 713.8	$ 1,999.4	$ 2,132.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization (including costs incurred from related parties of $48.8 during the nine months ended September 30, 2023)	526.6	563.8	1,606.1	1,674.0
Selling, general and administrative expenses, exclusive of depreciation and amortization	136.3	106.8	412.6	321.4
Depreciation and amortization	21.2	22.8	64.5	67.1
Restructuring and other charges	8.8	10.1	22.5	14.3
Total costs and expenses	692.9	703.5	2,105.7	2,076.8
Operating income (loss)	(18.0)	10.3	(106.3)	56.0
Other income (expense):
Interest expense	(22.4)	(34.6)	(101.9)	(35.2)
Foreign exchange loss	(0.2)	(1.2)	(7.0)	(1.2)
Other, net	4.8	3.6	15.1	4.6
Income (loss) from continuing operations before income taxes	(35.8)	(21.9)	(200.1)	24.2
Income tax (benefit) expense	(17.3)	(5.8)	(2.5)	7.3
Income (loss) from continuing operations	(18.5)	(16.1)	(197.6)	16.9
Income (loss) from discontinued operations, net of tax	(9.4)	2.1	(69.7)	12.4
Net income (loss)	$ (27.9)	$ (14.0)	$ (267.3)	$ 29.3
Earnings (loss) per common share
Basic earnings (loss) per share from continuing operations (in dollars per share)	$ (0.21)	$ (0.18)	$ (2.21)	$ 0.19
Basic earnings (loss) per share form discontinued operations (in dollars per share)	(0.10)	0.02	(0.78)	0.14
Basic earnings (loss) per share (in dollars per share)	(0.31)	(0.16)	(2.99)	0.33
Diluted earnings (loss) per share continuing from operations (in dollars per share)	(0.21)	(0.18)	(2.21)	0.19
Diluted earnings (loss) per share from discontinued operations (in dollars per share)	(0.10)	0.02	(0.78)	0.14
Diluted earnings (loss) per share (in dollars per share)	$ (0.31)	$ (0.16)	$ (2.99)	$ 0.33

RESTRUCTURING AND OTHER CHARGES - Schedule of Restructuring and Other Charges (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Restructuring Reserve [Roll Forward]
Beginning balance	$ 4.3	$ 6.3
Restructuring charges	16.7	10.6
Reduction of prior restructuring accruals	(3.9)
Cash payments and other adjustments	(14.8)	(9.6)
Ending balance	2.3	7.3
Severance and Other Employee Costs
Restructuring Reserve [Roll Forward]
Beginning balance	1.1	1.8
Restructuring charges	16.0	9.7
Reduction of prior restructuring accruals	(0.9)
Cash payments and other adjustments	(14.2)	(8.4)
Ending balance	2.0	3.1
Facility Costs
Restructuring Reserve [Roll Forward]
Beginning balance	3.2	4.5
Restructuring charges	0.7	0.9
Reduction of prior restructuring accruals	(3.0)
Cash payments and other adjustments	(0.6)	(1.2)
Ending balance	$ 0.3	$ 4.2

PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) are as follows:


	Foreign Currency Translation Adjustments		Net Benefit Plan Adjustments		Unrealized Gain (Loss) on Derivative Instruments		Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2023	$	(206.7)	$	(7.4)	$	(1.4)	$	(215.5)
Current quarter foreign exchange adjustments	(27.7)		—		—		(27.7)
Unrealized gain on derivative instrument	—		—		2.5		2.5
Amounts reclassified from other accumulated income (loss)	—		—		(0.4)		(0.4)
Tax effect of adjustments	—		—		(0.5)		(0.5)
Balance at March 31, 2024	(234.4)		(7.4)		0.2		(241.6)
Current quarter foreign exchange adjustments	(7.7)		—		—		(7.7)
Unrealized gain on derivative instrument	—		—		0.8		0.8
Amounts reclassified from other accumulated income (loss)	—		—		(0.4)		(0.4)
Tax effect of adjustments	—		—		(0.1)		(0.1)
Balance at June 30, 2024	(242.1)		(7.4)		0.5		(249.0)
Current quarter foreign exchange adjustments	73.4		—		—		73.4
Unrealized gain on derivative instrument	—		—		(2.9)		(2.9)
Amounts reclassified from other accumulated income (loss)	—		—		(0.4)		(0.4)
Tax effect of adjustments	—		—		0.8		0.8
Balance at September 30, 2024	$	(168.7)	$	(7.4)	$	(2.0)	$	(178.1)


	Foreign Currency Translation Adjustments		Net Benefit Plan Adjustments		Unrealized Gain (Loss) on Derivative Instruments		Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022	$	(266.0)	$	(8.8)	$	—	$	(274.8)
Current quarter foreign exchange adjustments	19.1		—		—		19.1
Tax effect of adjustments	—		—		—		—
Balance at March 31, 2023	(246.9)		(8.8)		—		(255.7)
Current quarter foreign exchange adjustments	29.9		—		—		29.9
Net benefit plan adjustments	—		2.1		—		2.1
Tax effect of adjustments	—		—		—		—
Balance at June 30, 2023	(217.0)		(6.7)		—		(223.7)
Current quarter foreign exchange adjustments	(55.6)		—		—		(55.6)
Unrealized gain on derivative instrument	—		—		1.6		1.6
Tax effect of adjustments	—		—		(0.4)		(0.4)
Balance at September 30, 2023	$	(272.6)	$	(6.7)	$	1.2	$	(278.1)

STOCK COMPENSATION PLANS - Narrative (Details) - Restricted Stock Units (RSUs) - $ / shares shares in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, equity instruments other than option (in shares)	0.1	1.1
Weighted average grant date fair (in dollars per share)	$ 21.39	$ 37.62

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

BASIS OF FINANCIAL STATEMENT PREPARATION (Details) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) segment country	Sep. 30, 2023 USD ($)	Dec. 31, 2023
Concentration Risk [Line Items]
Number of reportable segments \| segment			1
Number of operating segments \| segment			1
Number of countries with primary office locations \| country			5
Selling, general and administrative expenses, exclusive of depreciation and amortization	$ 136.3	$ 106.8	$ 412.6	$ 321.4
Decrease of direct costs	$ (526.6)	(563.8)	$ (1,606.1)	(1,674.0)
Interest expense				0.1
Reclassifications
Concentration Risk [Line Items]
Selling, general and administrative expenses, exclusive of depreciation and amortization		39.0		117.3
Decrease of direct costs		$ (39.0)		$ (117.3)
Customer one \| Accounts receivable and unbilled services \| Customer concentration risk
Concentration Risk [Line Items]
Concentration risk, percentage			15.60%
Customer one \| Revenue \| Customer concentration risk
Concentration Risk [Line Items]
Concentration risk, percentage	15.10%	14.60%	14.20%	11.10%
Pharmaceutical company one \| Accounts receivable and unbilled services \| Customer concentration risk
Concentration Risk [Line Items]
Concentration risk, percentage					17.00%
Pharmaceutical company two \| Accounts receivable and unbilled services \| Customer concentration risk
Concentration Risk [Line Items]
Concentration risk, percentage					11.20%
Customer two \| Revenue \| Customer concentration risk
Concentration Risk [Line Items]
Concentration risk, percentage		11.40%	10.40%	10.60%

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS - Statements of Operations (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues	$ 674.9	$ 713.8	$ 1,999.4	$ 2,132.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	526.6	563.8	1,606.1	1,674.0
Selling, general and administrative expenses, exclusive of depreciation and amortization	136.3	106.8	412.6	321.4
Depreciation and amortization	21.2	22.8	64.5	67.1
Restructuring and other charges	8.8	10.1	22.5	14.3
Total costs and expenses	692.9	703.5	2,105.7	2,076.8
Operating income (loss)	(18.0)	10.3	(106.3)	56.0
Other income (expense):
Interest expense		(34.6)		(35.2)
Foreign exchange loss	(0.2)	(1.2)	(7.0)	(1.2)
Other, net	4.8	3.6	15.1	4.6
Income (loss) from continuing operations before income taxes	(35.8)	(21.9)	(200.1)	24.2
Income tax (benefit) expense	(17.3)	(5.8)	(2.5)	7.3
Income (loss) from continuing operations	$ (18.5)	$ (16.1)	$ (197.6)	$ 16.9
Earnings (loss) per common share
Basic earnings (loss) per share continuing operations (in dollars per share)	$ (0.21)	$ (0.18)	$ (2.21)	$ 0.19
Basic earnings (loss) per share discontinued operations (in dollars per share)	(0.10)	0.02	(0.78)	0.14
Basic earnings (loss) per share (in dollars per share)	(0.31)	(0.16)	(2.99)	0.33
Diluted earnings (loss) per share continuing operations (in dollars per share)	(0.21)	(0.18)	(2.21)	0.19
Diluted earnings (loss) per share discontinued operations (in dollars per share)	(0.10)	0.02	(0.78)	0.14
Diluted earnings (loss) per share (in dollars per share)	$ (0.31)	$ (0.16)	$ (2.99)	$ 0.33
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues		$ 776.4		$ 2,333.6
Costs and expenses:
Direct costs, exclusive of depreciation and amortization		647.3		1,932.9
Selling, general and administrative expenses, exclusive of depreciation and amortization		78.9		237.7
Depreciation and amortization		24.6		72.5
Restructuring and other charges		11.6		16.7
Total costs and expenses		762.4		2,259.8
Operating income (loss)		14.0		73.8
Other income (expense):
Interest expense		(34.6)		(35.3)
Foreign exchange loss		(0.9)		(1.0)
Other, net		3.6		4.6
Income (loss) from continuing operations before income taxes		(17.9)		42.1
Income tax (benefit) expense		(4.8)		9.5
Income (loss) from continuing operations		$ (13.1)		$ 32.6
Earnings (loss) per common share
Basic earnings (loss) per share continuing operations (in dollars per share)		$ (0.15)		$ 0.37
Basic earnings (loss) per share discontinued operations (in dollars per share)		0		0
Basic earnings (loss) per share (in dollars per share)		(0.15)		0.37
Diluted earnings (loss) per share continuing operations (in dollars per share)		(0.15)		0.37
Diluted earnings (loss) per share discontinued operations (in dollars per share)		0		0
Diluted earnings (loss) per share (in dollars per share)		$ (0.15)		$ 0.37
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues		$ 0.8		$ (2.8)
Costs and expenses:
Direct costs, exclusive of depreciation and amortization		1.4		0.2
Selling, general and administrative expenses, exclusive of depreciation and amortization		(0.1)		(0.3)
Depreciation and amortization		0.4		1.1
Restructuring and other charges		0.0		0.0
Total costs and expenses		1.7		1.0
Operating income (loss)		(0.9)		(3.8)
Other income (expense):
Interest expense		0.0		0.0
Foreign exchange loss		(0.2)		(0.4)
Other, net		0.0		0.0
Income (loss) from continuing operations before income taxes		(1.1)		(4.2)
Income tax (benefit) expense		(0.2)		(0.9)
Income (loss) from continuing operations		(0.9)		(3.3)
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues		777.2		2,330.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization		648.7		1,933.1
Selling, general and administrative expenses, exclusive of depreciation and amortization		78.8		237.4
Depreciation and amortization		25.0		73.6
Restructuring and other charges		11.6		16.7
Total costs and expenses		764.1		2,260.8
Operating income (loss)		13.1		70.0
Other income (expense):
Interest expense		(34.6)		(35.3)
Foreign exchange loss		(1.1)		(1.4)
Other, net		3.6		4.6
Income (loss) from continuing operations before income taxes		(19.0)		37.9
Income tax (benefit) expense		(5.0)		8.6
Income (loss) from continuing operations		$ (14.0)		$ 29.3
Earnings (loss) per common share
Basic earnings (loss) per share continuing operations (in dollars per share)		$ (0.16)		$ 0.33
Basic earnings (loss) per share discontinued operations (in dollars per share)		0		0
Basic earnings (loss) per share (in dollars per share)		(0.16)		0.33
Diluted earnings (loss) per share continuing operations (in dollars per share)		(0.16)		0.33
Diluted earnings (loss) per share discontinued operations (in dollars per share)		0		0
Diluted earnings (loss) per share (in dollars per share)		$ (0.16)		$ 0.33
Reclassifications
Costs and expenses:
Direct costs, exclusive of depreciation and amortization		$ 39.0		$ 117.3
Selling, general and administrative expenses, exclusive of depreciation and amortization		39.0		117.3
Reclassifications \| Discontinued Operations Reclassifications
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues		(63.4)		(198.0)
Costs and expenses:
Direct costs, exclusive of depreciation and amortization		(44.8)		(135.2)
Selling, general and administrative expenses, exclusive of depreciation and amortization		(12.1)		(39.9)
Depreciation and amortization		(2.2)		(6.5)
Restructuring and other charges		(1.5)		(2.4)
Total costs and expenses		(60.6)		(184.0)
Operating income (loss)		(2.8)		(14.0)
Other income (expense):
Interest expense		0.0		0.0
Foreign exchange loss		(0.1)		0.2
Other, net		0.0		0.1
Income (loss) from continuing operations before income taxes		(2.9)		(13.7)
Income tax (benefit) expense		(0.8)		(1.3)
Income (loss) from continuing operations		(2.1)		(12.4)
Reclassifications \| Change in Basis of Presentation
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues		0.0		0.0
Costs and expenses:
Direct costs, exclusive of depreciation and amortization		(40.1)		(123.9)
Selling, general and administrative expenses, exclusive of depreciation and amortization		40.1		123.9
Depreciation and amortization		0.0		0.0
Restructuring and other charges		0.0		0.0
Total costs and expenses		0.0		0.0
Operating income (loss)		0.0		0.0
Other income (expense):
Interest expense		0.0		0.1
Foreign exchange loss		0.0		0.0
Other, net		0.0		(0.1)
Income (loss) from continuing operations before income taxes		0.0		0.0
Income tax (benefit) expense		0.0		0.0
Income (loss) from continuing operations		$ 0.0		$ 0.0

EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Basic earnings (loss) from continuing operations per share:
Net earnings (loss)	$ (18.5)	$ (16.1)	$ (197.6)	$ 16.9
Net earnings (loss) from continuing operations including impact of dilutive adjustments	$ (18.5)	$ (16.1)	$ (197.6)	$ 16.9
Outstanding shares, basic (in shares)	89.6	88.8	89.4	88.8
Dilutive effect of employee awards (in shares)	0.0	0.0	0.0	0.2
Outstanding shares, diluted (in shares)	89.6	88.8	89.4	89.0
Per share amount, basic (in dollars per share)	$ (0.21)	$ (0.18)	$ (2.21)	$ 0.19
Per share amount, diluted (in dollars per share)	$ (0.21)	$ (0.18)	$ (2.21)	$ 0.19
Basic earnings (loss) from discontinued operations per share:
Net earnings (loss)	$ (9.4)	$ 2.1	$ (69.7)	$ 12.4
Net earnings (loss) from discontinued operations including impact of dilutive adjustments	$ (9.4)	$ 2.1	$ (69.7)	$ 12.4
Outstanding shares, basic (in shares)	89.6	88.8	89.4	88.8
Dilutive effect of employee awards (in shares)	0.0	0.0	0.0	0.2
Outstanding shares, diluted (in shares)	89.6	88.8	89.4	89.0
Per share amount, basic (in dollars per share)	$ (0.10)	$ 0.02	$ (0.78)	$ 0.14
Per share amount, diluted (in dollars per share)	$ (0.10)	$ 0.02	$ (0.78)	$ 0.14

COVER - shares shares in Millions	9 Months Ended
COVER - shares shares in Millions	Sep. 30, 2024	Nov. 06, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-41704
Entity Registrant Name	FORTREA HOLDINGS INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	92-2796441
Entity Address, Address Line One	8 Moore Drive
Entity Address, City or Town	Durham
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27709
City Area Code	(480)
Local Phone Number	295-7600
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	FTRE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		89.7
Amendment Flag	false
Entity Central Index Key	0001965040
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31

TRANSACTIONS WITH FORMER PARENT

9 Months Ended

Sep. 30, 2024

TRANSACTIONS WITH FORMER PARENT

Prior to the Separation on June 30, 2023, the condensed consolidated and combined financial statements were prepared on a standalone basis and were derived from the condensed consolidated financial statements and accounting records of Labcorp. The following discussion summarizes activity between the Company and Labcorp. This activity, which occurred prior to the Separation, is included in the condensed combined financial statements in 2023.

Allocation of General Corporate and Other Expenses

Prior to the Separation, the Company’s condensed consolidated and combined statements of operations included expenses for certain centralized functions and other programs provided and administered by Labcorp that were charged directly to the Company. In addition, for purposes of preparing these condensed consolidated and combined financial statements on a carve-out basis, a portion of Labcorp’s total corporate expenses were allocated to the Company. See Note 1 - Basis of Financial Statement Presentation for a discussion of the methodology used to allocate corporate-related costs for purposes of preparing these financial statements on a carve-out basis. Some of these services continue to be provided by Labcorp to the Company on a temporary basis under the Transition Services Agreement with Labcorp.

The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023:



	Three Months Ended September 30, 2023		Nine Months Ended September 30, 2023
Direct costs	$	—	$	86.6
Selling, general and administrative expenses	—		105.0
Restructuring and other charges	—		0.2
Foreign exchange gain (loss)	—		2.2
Corporate and other allocations	$	—	$	194.0

Included in the aforementioned amounts are $0.0 and $147.6 related to costs for certain centralized functions and programs provided and administered by Labcorp that were charged directly to the Company for the three and nine months ended September 30, 2023, respectively. In addition, a portion of Labcorp’s total corporate expenses were allocated to the Company for services from Labcorp. These costs were $0.0 and $46.4 for the three and nine months ended September 30, 2023, respectively. The allocations of foreign exchange gain (loss) represent the allocation of the results of hedging activities performed by Labcorp on behalf of the Company prior to the Separation.

The Company had arrangements with third parties where the services are subcontracted to Labcorp (and its affiliates that were not part of the transaction). The Company’s direct costs include services purchased from Labcorp for commercial contracts totaling $0.0 and $48.8 for the three and nine months ended September 30, 2023, respectively.

Hedging Activities

Prior to the Separation, the Company did not enter into any derivative contracts with external counterparties. However, Labcorp entered into foreign currency forward contracts with external counterparties to hedge certain foreign currency transactions with exposure predominantly to the Euro and British Pound. These contracts did not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. Earnings related to these contracts were included in the condensed consolidated and combined statements of operations as part of corporate allocations. Refer to Note 7 - Derivative Instruments and Hedging Activities, for information regarding derivative contracts entered into after Separation.

Net Transfers To and From Labcorp

Net transfers to and from Labcorp are included within Former Parent company investment on the condensed consolidated and combined statements of changes in equity. The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 were as follows:


	Three Months Ended September 30, 2023		Nine Months Ended September 30, 2023
Special Payment to Former Parent	$	—	$	(1,595.0)
General financing activities	—		(286.8)
Corporate allocations	—		184.9
Stock compensation expense	—		10.2
Total net transfers (to) from Former Parent	$	—	$	(1,686.7)

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS - Statements of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (27.9)	$ (138.4)	$ (101.0)	$ (14.0)	$ 30.8	$ 12.5	$ (267.3)	$ 29.3
Foreign currency translation adjustments	73.4			(55.6)			38.0	(6.6)
Net benefit plan adjustments	0.0			0.0			0.0	2.1
Unrealized gain on derivative instruments	(3.3)			1.6			(0.8)	1.6
Other comprehensive income (loss) before tax	70.1			(54.0)			37.2	(2.9)
Income tax expense related to items of comprehensive loss	0.8			(0.4)			0.2	(0.4)
Other comprehensive income (loss), net of tax	70.9	$ (7.4)	$ (26.1)	(54.4)	32.0	19.1	37.4	(3.3)
Comprehensive income (loss)	$ 43.0			(68.4)			$ (229.9)	26.0
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)				(13.1)	28.3	17.4		32.6
Foreign currency translation adjustments				(56.0)				(7.6)
Net benefit plan adjustments								2.1
Unrealized gain on derivative instruments				1.6				1.6
Other comprehensive income (loss) before tax				(54.4)				(3.9)
Income tax expense related to items of comprehensive loss				(0.4)				(0.4)
Other comprehensive income (loss), net of tax				(54.8)	31.6	18.9		(4.3)
Comprehensive income (loss)				(67.9)				28.3
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)				(0.9)	2.5	(4.9)		(3.3)
Foreign currency translation adjustments				0.4				1.0
Net benefit plan adjustments								0.0
Unrealized gain on derivative instruments				0.0				0.0
Other comprehensive income (loss) before tax				0.4				1.0
Income tax expense related to items of comprehensive loss				0.0				0.0
Other comprehensive income (loss), net of tax				0.4	$ 0.4	$ 0.2		1.0
Comprehensive income (loss)				$ (0.5)				$ (2.3)

COMMITMENTS AND CONTINGENT LIABILITIES	9 Months Ended
COMMITMENTS AND CONTINGENT LIABILITIES	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	COMMITMENTS AND CONTINGENT LIABILITIES The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. These matters may include commercial and contract disputes, employee-related matters, and professional liability claims. In accordance with FASB ASC 450, Contingencies, the Company establishes reserves for claims and legal actions when those matters present loss contingencies that are both probable and estimable. When loss contingencies are not both probable and estimable, the Company does not establish reserves. The Company does not believe that any liabilities related to such claims and legal actions will have a material effect on its financial condition, results of operations or cash flows. The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its drug development support services. The drug development industry is, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, and/or additional liabilities from third-party claims. Fortrea obtains insurance coverage for certain catastrophic exposures as well as those risks required to be insured by law or contract. The Company is covered by those policies but is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers’ compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company’s estimates of the aggregated liability of claims incurred. It was previously disclosed that there was an issue in a customer’s trial caused by a third-party vendor not affiliated with the Company. As part of working with this customer, the Company agreed to make concessions and provide discounts and other consideration to the customer in the amount of $12.5 as part of a multi-party solution to facilitate the ongoing trials, of which $0.9 and $3.0 was recorded as a reduction of revenue during the three and nine months ended September 30, 2024, respectively, and $8.7 was recorded as a reduction in revenue in the fourth quarter of 2023.

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net income (loss)	$ (27.9)	$ (138.4)	$ (101.0)	$ (14.0)	$ 30.8	$ 12.5	$ (267.3)	$ 29.3

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax Effects of Cash Flow Hedges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Pre-Tax Gain (Loss) Included in Other Comprehensive Income	$ (2.9)	$ 0.0	$ 0.4	$ 0.0

TRANSACTIONS WITH FORMER PARENT - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction	$ 0.0	$ 194.0
General financing activities
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction	0.0	147.6
Corporate allocations
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction	0.0	46.4
Subcontract services
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction	$ 0.0	$ 48.8

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Former Parent Investment	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		0.0
Beginning balance at Dec. 31, 2022	$ 3,340.0	$ 0.0	$ 0.0	$ 3,614.8	$ 0.0	$ (274.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	12.5			12.5
Other comprehensive income (loss), net of tax	19.1					19.1
Net transfers from Former Parent	31.2			31.2
Ending balance (in shares) at Mar. 31, 2023		0.0
Ending balance at Mar. 31, 2023	3,402.8	$ 0.0	0.0	3,658.5	0.0	(255.7)
Beginning balance (in shares) at Dec. 31, 2022		0.0
Beginning balance at Dec. 31, 2022	3,340.0	$ 0.0	0.0	3,614.8	0.0	(274.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	29.3
Other comprehensive income (loss), net of tax	(3.3)
Ending balance (in shares) at Sep. 30, 2023		88.8
Ending balance at Sep. 30, 2023	1,690.5	$ 0.1	1,982.5	0.0	(14.0)	(278.1)
Beginning balance (in shares) at Mar. 31, 2023		0.0
Beginning balance at Mar. 31, 2023	3,402.8	$ 0.0	0.0	3,658.5	0.0	(255.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	30.8			30.8
Other comprehensive income (loss), net of tax	32.0					32.0
Special payment to Former Parent	(1,595.0)			(1,595.0)
Net transfers from Former Parent	(122.9)			(122.9)
Reclassification of Former Parent investment to additional paid-in capital	0.0		1,971.4	(1,971.4)
Issuance of common stock (in shares)		88.8
Issuance of common stock	$ 0.1	$ 0.1
Ending balance (in shares) at Jun. 30, 2023	88.8	88.8
Ending balance at Jun. 30, 2023	$ 1,747.8	$ 0.1	1,971.4	0.0	0.0	(223.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(14.0)				(14.0)
Other comprehensive income (loss), net of tax	(54.4)					(54.4)
Stock compensation	11.1		11.1
Ending balance (in shares) at Sep. 30, 2023		88.8
Ending balance at Sep. 30, 2023	$ 1,690.5	$ 0.1	1,982.5	0.0	(14.0)	(278.1)
Beginning balance (in shares) at Dec. 31, 2023	88.8	88.8
Beginning balance at Dec. 31, 2023	$ 1,714.1	$ 0.1	1,998.0	0.0	(68.5)	(215.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(101.0)				(101.0)
Other comprehensive income (loss), net of tax	(26.1)					(26.1)
Stock compensation	15.1		15.1
Issuance of common stock (in shares)		0.6
Net share settlement tax payments from issuance of stock to employees	(10.4)		(10.4)
Other	0.2		0.2
Ending balance (in shares) at Mar. 31, 2024		89.4
Ending balance at Mar. 31, 2024	$ 1,591.9	$ 0.1	2,002.9	0.0	(169.5)	(241.6)
Beginning balance (in shares) at Dec. 31, 2023	88.8	88.8
Beginning balance at Dec. 31, 2023	$ 1,714.1	$ 0.1	1,998.0	0.0	(68.5)	(215.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(267.3)
Other comprehensive income (loss), net of tax	$ 37.4
Ending balance (in shares) at Sep. 30, 2024	89.7	89.7
Ending balance at Sep. 30, 2024	$ 1,513.5	$ 0.1	2,027.3	0.0	(335.8)	(178.1)
Beginning balance (in shares) at Mar. 31, 2024		89.4
Beginning balance at Mar. 31, 2024	1,591.9	$ 0.1	2,002.9	0.0	(169.5)	(241.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(138.4)				(138.4)
Other comprehensive income (loss), net of tax	(7.4)					(7.4)
Stock compensation	15.0		15.0
Issuance of common stock (in shares)		0.1
Ending balance (in shares) at Jun. 30, 2024		89.5
Ending balance at Jun. 30, 2024	1,461.1	$ 0.1	2,017.9	0.0	(307.9)	(249.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(27.9)				(27.9)
Other comprehensive income (loss), net of tax	70.9					70.9
Stock compensation	13.0		13.0
Issuance of common stock (in shares)		0.2
Net share settlement tax payments from issuance of stock to employees	$ (3.6)		(3.6)
Ending balance (in shares) at Sep. 30, 2024	89.7	89.7
Ending balance at Sep. 30, 2024	$ 1,513.5	$ 0.1	$ 2,027.3	$ 0.0	$ (335.8)	$ (178.1)

EARNINGS (LOSS) PER SHARE - Narrative (Details) shares in Millions	Sep. 30, 2024 shares	Dec. 31, 2023 shares	Jun. 30, 2023 shares	Jun. 20, 2023
Earnings Per Share [Abstract]
Common stock, conversion ratio upon separation				1
Common stock, outstanding (in shares)	89.7	88.8	88.8

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Reclassified from Other Comprehensive Loss into Earnings (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest rate swaps \| Interest expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amounts Reclassified from Other Comprehensive Loss into Earnings	$ (0.4)	$ 0.0	$ (1.2)	$ 0.0

REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Accounts receivable	$ 156.2	$ 420.2
Unbilled services	569.9	600.0
Less: allowance for credit losses	(37.0)	(31.7)
Total	689.1	988.5
Unearned revenue	$ 321.1	$ 214.2

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS (Tables)

9 Months Ended

Sep. 30, 2024

Accounting Changes and Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

CONSOLIDATED BALANCE SHEET


	As of December 31, 2023
	As Previously Reported		Adjustments		As Restated		Discontinued Operations Reclassifications		As Restated and Reclassified
ASSETS
Current assets:
Cash and cash equivalents	$	108.6	$	—	$	108.6	$	—	$	108.6
Accounts receivable and unbilled services, net	1,052.1		(3.2)		1,048.9		(60.4)		988.5
Prepaid expenses and other	92.4		0.9		93.3		(8.7)		84.6
Current assets held for sale from discontinued operations	—		—		—		69.1		69.1
Total current assets	1,253.1		(2.3)		1,250.8		—		1,250.8
Property, plant and equipment, net	220.9		(7.7)		213.2		(40.6)		172.6
Goodwill, net	2,029.3		(13.4)		2,015.9		(276.5)		1,739.4
Intangible assets, net	771.2		—		771.2		(43.1)		728.1
Deferred income taxes	3.2		—		3.2		—		3.2
Other assets, net	79.5		(1.2)		78.3		(8.6)		69.7
Long-term assets held for sale from discontinued operations	—		—		—		368.8		368.8
Total assets	$	4,357.2	$	(24.6)	$	4,332.6	$	—	$	4,332.6
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	132.8	$	4.6	$	137.4	$	(4.5)	$	132.9
Accrued expenses and other current liabilities	356.1		(3.3)		352.8		(17.3)		335.5
Unearned revenue	241.4		1.2		242.6		(28.4)		214.2
Current portion of long-term debt	26.1		—		26.1		—		26.1
Short-term operating lease liabilities	19.5		—		19.5		(2.3)		17.2
Current liabilities held for sale from discontinued operations	—		—		—		52.5		52.5
Total current liabilities	775.9		2.5		778.4		—		778.4
Long-term debt, less current portion	1,565.9		—		1,565.9		—		1,565.9
Operating lease liabilities	66.5		—		66.5		(3.7)		62.8
Deferred income taxes and other tax liabilities	148.8		(1.1)		147.7		—		147.7
Other liabilities	61.3		(1.3)		60.0		(27.9)		32.1
Long-term liabilities held for sale from discontinued operations	—		—		—		31.6		31.6
Total liabilities	2,618.4		0.1		2,618.5		—		2,618.5
Commitments and contingent liabilities
Equity
Former parent investment	—		—		—		—		—
Common stock	0.1		—		0.1		—		0.1
Additional paid-in capital	2,006.2		(8.2)		1,998.0		—		1,998.0
Accumulated deficit	(49.1)		(19.4)		(68.5)		—		(68.5)
Accumulated other comprehensive loss	(218.4)		2.9		(215.5)		—		(215.5)
Total equity	1,738.8		(24.7)		1,714.1		—		1,714.1
Total liabilities and equity	$	4,357.2	$	(24.6)	$	4,332.6	$	—	$	4,332.6

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS


	Three Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated		Discontinued Operations Reclassifications		Change in Basis of Presentation		As Restated and Reclassified
Revenues	$	776.4	$	0.8	$	777.2	$	(63.4)	$	—	$	713.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	647.3		1.4		648.7		(44.8)		(40.1)		563.8
Selling, general and administrative expenses, exclusive of depreciation and amortization	78.9		(0.1)		78.8		(12.1)		40.1		106.8
Depreciation and amortization	24.6		0.4		25.0		(2.2)		—		22.8

Restructuring and other charges	11.6		—		11.6		(1.5)		—		10.1
Total costs and expenses	762.4		1.7		764.1		(60.6)		—		703.5
Operating income (loss)	14.0		(0.9)		13.1		(2.8)		—		10.3
Other income (expense):
Interest expense	(34.6)		—		(34.6)		—		—		(34.6)
Foreign exchange gain (loss)	(0.9)		(0.2)		(1.1)		(0.1)		—		(1.2)
Other, net	3.6		—		3.6		—		—		3.6
Income (loss) before income taxes	(17.9)		(1.1)		(19.0)		(2.9)		—		(21.9)
Income tax (benefit) expense	(4.8)		(0.2)		(5.0)		(0.8)		—		(5.8)
Net loss	$	(13.1)	$	(0.9)	$	(14.0)	$	(2.1)	$	—	$	(16.1)



Earnings (loss) per common share:
Basic - continuing operations	$	(0.15)			$	(0.16)					$	(0.18)
Basic - discontinued operations	—				—						0.02
Basic	$	(0.15)			$	(0.16)					$	(0.16)

Diluted - continuing operations	$	(0.15)			$	(0.16)					$	(0.18)
Diluted - discontinued operations	—				—						0.02
Diluted	$	(0.15)			$	(0.16)					$	(0.16)

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF OPERATIONS


	Nine Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated		Discontinued Operations Reclassifications		Change in Basis of Presentation		As Restated and Reclassified
Revenues	$	2,333.6	$	(2.8)	$	2,330.8	$	(198.0)	$	—	$	2,132.8
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	1,932.9		0.2		1,933.1		(135.2)		(123.9)		1,674.0
Selling, general and administrative expenses, exclusive of depreciation and amortization	237.7		(0.3)		237.4		(39.9)		123.9		321.4
Depreciation and amortization	72.5		1.1		73.6		(6.5)		—		67.1

Restructuring and other charges	16.7		—		16.7		(2.4)		—		14.3
Total costs and expenses	2,259.8		1.0		2,260.8		(184.0)		—		2,076.8
Operating income (loss)	73.8		(3.8)		70.0		(14.0)		—		56.0
Other income (expense):
Interest expense	(35.3)		—		(35.3)		—		0.1		(35.2)
Foreign exchange gain (loss)	(1.0)		(0.4)		(1.4)		0.2		—		(1.2)
Other, net	4.6		—		4.6		0.1		(0.1)		4.6
Income (loss) before income taxes	42.1		(4.2)		37.9		(13.7)		—		24.2
Income tax (benefit) expense	9.5		(0.9)		8.6		(1.3)		—		7.3
Net income	$	32.6	$	(3.3)	$	29.3	$	(12.4)	$	—	$	16.9



Earnings per common share:
Basic - continuing operations	$	0.37			$	0.33					$	0.19
Basic - discontinued operations	—				—						0.14
Basic	$	0.37			$	0.33					$	0.33

Diluted - continuing operations	$	0.37			$	0.33					$	0.19
Diluted - discontinued operations	—				—						0.14
Diluted	$	0.37			$	0.33					$	0.33

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)


	Three Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated
Net loss	$	(13.1)	$	(0.9)	$	(14.0)
Foreign currency translation adjustments	(56.0)		0.4		(55.6)

Unrealized gain on derivative instruments	1.6		—		1.6
Other comprehensive loss, before tax	(54.4)		0.4		(54.0)
Income tax expense related to items of comprehensive loss	(0.4)		—		(0.4)
Other comprehensive loss, net of tax	(54.8)		0.4		(54.4)
Comprehensive loss	$	(67.9)	$	(0.5)	$	(68.4)

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF COMPREHENSIVE INCOME (LOSS)


	Nine Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated
Net income	$	32.6	$	(3.3)	$	29.3
Foreign currency translation adjustments	(7.6)		1.0		(6.6)
Net benefit plan adjustments	2.1		—		2.1
Unrealized gain on derivative instruments	1.6		—		1.6
Other comprehensive loss, before tax	(3.9)		1.0		(2.9)
Income tax expense related to items of comprehensive loss	(0.4)		—		(0.4)
Other comprehensive loss, net of tax	(4.3)		1.0		(3.3)
Comprehensive income	$	28.3	$	(2.3)	$	26.0

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF CHANGES IN EQUITY


	Common Stock
	Shares	Amounts		Additional Paid-in Capital		Former Parent Investment		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Equity
Previously reported
Balance at December 31, 2022	—	$	—	$	—	$	3,618.6	$	—	$	(276.0)	$	3,342.6
Net income	—	—		—		17.4		—		—		17.4
Other comprehensive income, net of tax	—	—		—		—		—		18.9		18.9
Net transfers from Former Parent	—	—		—		26.6		—		—		26.6
Balance at March 31, 2023	—	—		—		3,662.6		—		(257.1)		3,405.5
Net income	—	—		—		28.3		—		—		28.3
Other comprehensive income, net of tax	—	—		—		—		—		31.6		31.6
Special payment to Former Parent	—	—		—		(1,595.0)		—		—		(1,595.0)
Net transfers to Former Parent	—	—		—		(119.4)		—		—		(119.4)
Reclassification of Former Parent investment to additional paid-in capital	—	—		1,976.5		(1,976.5)		—		—		—
Issuance of common stock	88.8	0.1		—		—		—		—		0.1
Balance at June 30, 2023	88.8	0.1		1,976.5		—		—		(225.5)		1,751.1
Net loss	—	—		—		—		(13.1)		—		(13.1)
Other comprehensive loss, net of tax	—	—		—		—		—		(54.8)		(54.8)
Stock compensation	—	—		11.1		—		—		—		11.1
Balance at September 30, 2023	88.8	$	0.1	$	1,987.6	$	—	$	(13.1)	$	(280.3)	$	1,694.3
Adjustments
Balance at December 31, 2022	—	$	—	$	—	$	(3.8)	$	—	$	1.2	$	(2.6)
Net income	—	—		—		(4.9)		—		—		(4.9)
Other comprehensive income, net of tax	—	—		—		—		—		0.2		0.2
Net transfers from Former Parent	—	—		—		4.6		—		—		4.6
Balance at March 31, 2023	—	—		—		(4.1)		—		1.4		(2.7)
Net income	—	—		—		2.5		—		—		2.5
Other comprehensive income, net of tax	—	—		—		—		—		0.4		0.4

Net transfers to Former Parent	—	—		—		(3.5)		—		—		(3.5)
Reclassification of Former Parent investment to additional paid-in capital	—	—		(5.1)		5.1		—		—		—

Balance at June 30, 2023	—	—		(5.1)		—		—		1.8		(3.3)
Net loss	—	—		—		—		(0.9)		—		(0.9)
Other comprehensive loss, net of tax	—	—		—		—		—		0.4		0.4

Balance at September 30, 2023	—	$	—	$	(5.1)	$	—	$	(0.9)	$	2.2	$	(3.8)


	Common Stock
	Shares	Amounts		Additional Paid-in Capital		Former Parent Investment		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Equity

















As Restated
Balance at December 31, 2022	—	$	—	$	—	$	3,614.8	$	—	$	(274.8)	$	3,340.0
Net income	—	—		—		12.5		—		—		12.5
Other comprehensive income, net of tax	—	—		—		—		—		19.1		19.1
Net transfers from Former Parent	—	—		—		31.2		—		—		31.2
Balance at March 31, 2023	—	—		—		3,658.5		—		(255.7)		3,402.8
Net income	—	—		—		30.8		—		—		30.8
Other comprehensive income, net of tax	—	—		—		—		—		32.0		32.0
Special payment to Former Parent	—	—		—		(1,595.0)		—		—		(1,595.0)
Net transfers to Former Parent	—	—		—		(122.9)		—		—		(122.9)
Reclassification of Former Parent investment to additional paid-in capital	—	—		1,971.4		(1,971.4)		—		—		—
Issuance of common stock	88.8	0.1		—		—		—		—		0.1
Balance at June 30, 2023	88.8	0.1		1,971.4		—		—		(223.7)		1,747.8
Net loss	—	—		—		—		(14.0)		—		(14.0)
Other comprehensive loss, net of tax	—	—		—		—		—		(54.4)		(54.4)
Stock compensation	—	—		11.1		—		—		—		11.1
Balance at September 30, 2023	88.8	$	0.1	$	1,982.5	$	—	$	(14.0)	$	(278.1)	$	1,690.5

CONDENSED CONSOLIDATED AND COMBINED STATEMENT OF CASH FLOWS


	Nine Months Ended September 30, 2023
	As Previously Reported		Adjustments		As Restated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	32.6	$	(3.3)	$	29.3
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	72.5		1.1		73.6
Stock compensation	27.2		—		27.2
Operating lease right-of-use asset expense	20.9		—		20.9
Goodwill and other asset impairments	—		—		—
Deferred income taxes	(12.7)		(0.6)		(13.3)
Other, net	3.5		—		3.5
Change in assets and liabilities (net of effects of acquisitions):
Increase in accounts receivable and unbilled services, net	(26.6)		3.5		(23.1)
Decrease in prepaid expenses and other	(3.1)		3.7		0.6
Increase in accounts payable	47.3		(1.4)		45.9
Decrease in deferred revenue	(6.5)		0.5		(6.0)
Decrease in accrued expenses and other	(0.1)		(8.5)		(8.6)
Net cash provided by operating activities	155.0		(5.0)		150.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(30.9)		—		(30.9)
Proceeds from sale of assets	8.1		—		8.1
Net cash used for investing activities	(22.8)		—		(22.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities	24.0		—		24.0
Payments on revolving credit facilities	(24.0)		—		(24.0)
Proceeds from term loans	1,061.4		—		1,061.4
Proceeds from issuance of senior notes	570.0		—		570.0
Debt issuance costs	(26.4)		—		(26.4)
Principal payments of long-term debt	(7.7)		—		(7.7)
Special payment to Former Parent	(1,595.0)		—		(1,595.0)
Net transfers from Parent	(136.7)		1.3		(135.4)
Net cash used for financing activities	(134.4)		1.3		(133.1)
Effect of exchange rate changes on cash and cash equivalents	(2.3)		1.6		(0.7)
Net change in cash and cash equivalents	(4.5)		(2.1)		(6.6)
Cash and cash equivalents at beginning of period	112.0		(1.6)		110.4
Cash and cash equivalents at end of period	$	107.5	$	(3.7)	$	103.8

The cash flows related to discontinued operations have not been segregated and are included in the adjusted and restated statements of cash flows included above.

STOCK COMPENSATION PLANS (Tables)

9 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Compensation Expense

Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Direct costs	$	11.2	$	6.6	$	32.5	$	15.4
Selling, general and administrative expenses	1.8		3.8		9.4		10.1
Total stock compensation expense	$	13.0	$	10.4	$	41.9	$	25.5

Income tax benefits	$	2.1	$	1.7	$	6.4	$	4.4

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 105.3			$ 108.6
Accounts receivable and unbilled services, net	689.1			988.5
Prepaid expenses and other	142.5			84.6
Current assets of discontinued operations	0.0			69.1
Total current assets	936.9			1,250.8
Property, plant and equipment, net	173.1			172.6
Goodwill, net	1,767.0			1,739.4
Intangible assets, net	691.2			728.1
Deferred income taxes	3.2			3.2
Other assets, net	92.3			69.7
Long-term assets of discontinued operations	0.0			368.8
Total assets	3,663.7			4,332.6
Current liabilities:
Accounts payable	137.6			132.9
Accrued expenses and other current liabilities	323.1			335.5
Unearned revenue	321.1			214.2
Current portion of long-term debt	0.0			26.1
Short-term operating lease liabilities	14.0			17.2
Current liabilities of discontinued operations	0.0			52.5
Total current liabilities	795.8			778.4
Long-term debt, less current portion	1,124.5			1,565.9
Operating lease liabilities	65.4			62.8
Deferred income taxes and other tax liabilities	126.9			147.7
Other liabilities	37.6			32.1
Long-term liabilities of discontinued operations	0.0			31.6
Total liabilities	2,150.2			2,618.5
Commitments and contingent liabilities (Note 8)
Equity
Common stock, 89.7 and 88.8 shares outstanding at September 30, 2024 and December 31, 2023, respectively	0.1			0.1
Additional paid-in capital	2,027.3			1,998.0
Accumulated deficit	(335.8)			(68.5)
Accumulated other comprehensive loss	(178.1)			(215.5)
Total equity	1,513.5	$ 1,461.1	$ 1,591.9	1,714.1	$ 1,690.5	$ 1,747.8	$ 3,402.8	$ 3,340.0
Total liabilities and equity	$ 3,663.7			$ 4,332.6

REVENUES - Schedule of Capitalized Contract Cost (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Capitalized Contract Cost [Line Items]
Total contract assets	$ 22.0	$ 17.8
Sales commission assets
Capitalized Contract Cost [Line Items]
Total contract assets	20.6	15.8
Deferred contract costs
Capitalized Contract Cost [Line Items]
Total contract assets	$ 1.4	$ 2.0

DISCONTINUED OPERATIONS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 09, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Goodwill impairment charge			$ 24.0
Discontinued operations, disposed of by sale \| Enabling Services segment disposal
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations, consideration							$ 340.0
Discontinued operations, consideration, cash							295.0
Discontinued operations, consideration, liability							$ 45.0
Proceeds from sale of businesses		$ 281.6
Loss on disposal of discontinued operations	$ 0.0	$ 23.2		$ 0.0	$ 23.2	$ 0.0

TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details) - Related party - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Related Party Transaction [Line Items]
Total net transfers (to) from Former Parent	$ 0.0	$ (1,686.7)
Special Payment to Former Parent
Related Party Transaction [Line Items]
Total net transfers (to) from Former Parent	0.0	(1,595.0)
General financing activities
Related Party Transaction [Line Items]
Total net transfers (to) from Former Parent	0.0	(286.8)
Corporate allocations
Related Party Transaction [Line Items]
Total net transfers (to) from Former Parent	0.0	184.9
Stock compensation expense
Related Party Transaction [Line Items]
Total net transfers (to) from Former Parent	$ 0.0	$ 10.2

REVENUES - Rollforward of Allowance for Credit Losses (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses as of December, 2023	$ 31.7
Credit loss expense	17.0	$ 21.9
Write-offs	(11.6)
Foreign currency impact	(0.1)
Allowance for credit losses as of September 30, 2024	$ 37.0

EARNINGS (LOSS) PER SHARE

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

EARNINGS (LOSS) PER SHARE

On June 30, 2023, the Separation from Labcorp was effected through a pro-rata distribution of one share of the Company’s common stock for every share of Labcorp common stock held at the close of business on the record date of June 20, 2023. As a result, on June 30, 2023, the Company had 88.8 shares of common stock outstanding. This share amount is being utilized for the calculation of basic earnings per share for all periods presented through the Separation date. As of the Separation date, actual outstanding shares are used to calculate basic weighted average common shares outstanding. Basic earnings per share is computed by dividing net earnings attributable to the Company by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company’s outstanding stock options, restricted stock awards, restricted stock units (“RSUs”), and performance share awards.

The following represents a reconciliation of basic earnings (loss) per share to diluted earnings (loss) from continuing operations per share.


	Three Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from continuing operations per share:
Net earnings (loss)	$	(18.5)	89.6	$	(0.21)	$	(16.1)	88.8	$	(0.18)
Dilutive effect of employee stock options and awards	—		—	—		—		—	—
Net earnings (loss) from continuing operations including impact of dilutive adjustments	$	(18.5)	89.6	$	(0.21)	$	(16.1)	88.8	$	(0.18)


	Nine Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from continuing operations per share:
Net earnings (loss)	$	(197.6)	89.4	$	(2.21)	$	16.9	88.8	$	0.19
Dilutive effect of employee stock options and awards	—		—	—		—		0.2	—
Net earnings (loss) from continuing operations including impact of dilutive adjustments	$	(197.6)	89.4	$	(2.21)	$	16.9	89.0	$	0.19

The following represents a reconciliation of basic earnings (loss) per share to diluted earnings (loss) from discontinued operations per share.


	Three Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from discontinued operations per share:
Net earnings (loss)	$	(9.4)	89.6	$	(0.10)	$	2.1	88.8	$	0.02
Dilutive effect of employee stock options and awards	—		—	—		—		—	—
Net earnings (loss) from discontinued operations including impact of dilutive adjustments	$	(9.4)	89.6	$	(0.10)	$	2.1	88.8	$	0.02


	Nine Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from discontinued operations per share:
Net earnings (loss)	$	(69.7)	89.4	$	(0.78)	$	12.4	88.8	$	0.14
Dilutive effect of employee stock options and awards	—		—	—		—		0.2	—
Net earnings (loss) from discontinued operations including impact of dilutive adjustments	$	(69.7)	89.4	$	(0.78)	$	12.4	89.0	$	0.14

Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. Potential common shares are also considered antidilutive in the event of a net loss from operations.

The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Employee stock options and awards	2.8	0.5	2.0	1.5
Antidilutive employee stock options and awards excluded based on reporting a net loss for the period	0.5	0.4	0.9	—

DEBT - Narrative (Details) - USD ($)			3 Months Ended		9 Months Ended
DEBT - Narrative (Details) - USD ($)	Jun. 30, 2023	Jun. 27, 2023	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Aggregate principal amount issued			$ 1,640,000,000		$ 1,640,000,000
Maximum borrowing capacity			450,000,000.0		450,000,000.0
Repayments of long-term debt					482,700,000	$ 7,700,000
Write-off of debt issuance costs				$ 12,200,000	12,200,000	0
Proceeds from issuance of senior notes					0	570,000,000.0
Proceeds from term loans					0	$ 1,061,400,000
Letters of credit outstanding			0		0
Senior secured term loan A due 2028 \| Line of credit \| Secured debt
Debt Instrument [Line Items]
Aggregate principal amount issued	$ 500,000,000.0
Repayments of long-term debt			$ 0.0		$ 70,200,000
Debt term	5 years
Proceeds from term loans	$ 491,800,000
Effective interest rate			6.82%		6.82%
Senior secured term loan B due 2030 \| Line of credit \| Secured debt
Debt Instrument [Line Items]
Aggregate principal amount issued	$ 570,000,000.0
Repayments of long-term debt			$ 0.0		$ 412,500,000
Debt term	7 years
Proceeds from term loans	$ 552,900,000
Effective interest rate			8.49%		8.49%
7.5% senior notes due 2030 \| Senior notes
Debt Instrument [Line Items]
Aggregate principal amount issued		$ 570,000,000.0
Stated interest rate		7.50%	7.50%		7.50%
Proceeds from issuance of senior notes		$ 560,200,000
Senior secured revolving credit facility \| Line of credit \| Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 450,000,000.0
Effective interest rate			6.82%		6.82%
Line of credit, outstanding balance			$ 0		$ 0		$ 0
Available borrowing capacity			$ 450,000,000.0		$ 450,000,000.0
Commitment fee	0.35%
Annual agency fee	$ 100,000
Senior secured revolving credit facility \| Line of credit \| Swingline sub-facility
Debt Instrument [Line Items]
Maximum borrowing capacity	75,000,000.0
Senior secured revolving credit facility \| Line of credit \| Letter of credit
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 75,000,000.0

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gain (Loss) for Derivative Contracts Not Designated as Hedges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Foreign currency forward contracts \| Foreign exchange gain (loss)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (Loss) on Derivatives Recognized in Earnings	$ 1.0	$ 0.0	$ 0.6	$ 0.0

DISCONTINUED OPERATIONS (Tables)

9 Months Ended

Sep. 30, 2024

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Discontinued Operations

The following table summarizes the significant line items included in earnings (loss) from discontinued operations, net of income tax in the condensed consolidated and combined statements of operations for the three and nine months ended September 30, 2024 and 2023:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Revenues	$	—	$	63.4	$	106.4	$	198.0
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	—		44.8		66.4		135.2
Selling, general and administrative expenses, exclusive of depreciation and amortization	—		12.1		25.4		39.9
Depreciation and amortization	—		2.2		1.6		6.5
Long-lived and goodwill asset impairments	—		—		24.0		—
Restructuring and other charges	—		1.5		0.5		2.4
Total costs and expenses	—		60.6		117.9		184.0
Operating income (loss)	—		2.8		(11.5)		14.0
Other expense:

Foreign exchange gain (loss)	—		0.1		0.1		(0.2)
Loss on sale of a business	—		—		(23.2)		—
Other, net	—		—		0.1		(0.1)
Income (loss) from discontinued operations before income taxes	—		2.9		(34.5)		13.7
Income tax expense	9.4		0.8		35.2		1.3
Income (loss) from discontinued operations, net of tax	$	(9.4)	$	2.1	$	(69.7)	$	12.4


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Gain (loss) from operations of discontinued component	$	(9.4)	$	2.1	$	(46.5)	$	12.4
Loss on disposal of discontinued operations	—		—		(23.2)		—
Gain (loss) on discontinued operations	$	(9.4)	$	2.1	$	(69.7)	$	12.4

The following table summarizes the carrying value of the significant classes of assets and liabilities classified as discontinued operations as of December 31, 2023:


	December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	—
Accounts receivable and unbilled services, net	60.4
Prepaid expenses and other	8.7
Total current assets	69.1
Property, plant and equipment, net	40.6
Goodwill, net	276.5
Intangible assets, net	43.1

Other assets, net	8.6
Total assets of discontinued operations	$	437.9
LIABILITIES
Current liabilities:
Accounts payable	$	4.5
Accrued expenses and other current liabilities	17.3
Unearned revenue	28.4
Short-term operating lease liabilities	2.3
Total current liabilities	52.5
Operating lease liabilities	3.7

Other liabilities	27.9
Total liabilities of discontinued operations	$	84.1

The following table summarizes depreciation and amortization, capital expenditures and the significant cash flow and noncash items from discontinued operations for the nine months ended September 30, 2024 and 2023:


	Nine months ended September 30,
	2024		2023
Depreciation and amortization	$	1.6	$	6.5
Goodwill impairment	24.0		—
Loss on sale of business	23.2		—
Capital expenditures	7.4		12.0

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-SubTopic 10
-Topic 360
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-11

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 20
-Topic 205
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3

+ Details

DISCONTINUED OPERATIONS - Earnings from Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Other expense:
Income (loss) from discontinued operations, net of tax	$ (9.4)		$ 2.1	$ (69.7)	$ 12.4
Discontinued operations, disposed of by sale \| Enabling Services segment disposal
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	0.0		63.4	106.4	198.0
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	0.0		44.8	66.4	135.2
Selling, general and administrative expenses, exclusive of depreciation and amortization	0.0		12.1	25.4	39.9
Depreciation and amortization	0.0		2.2	1.6	6.5
Long-lived and goodwill asset impairments	0.0		0.0	24.0	0.0
Restructuring and other charges	0.0		1.5	0.5	2.4
Total costs and expenses	0.0		60.6	117.9	184.0
Operating income (loss)	0.0		2.8	(11.5)	14.0
Other expense:
Foreign exchange gain (loss)	0.0		0.1	0.1	(0.2)
Loss on sale of a business	0.0		0.0	(23.2)	0.0
Other, net	0.0		0.0	0.1	(0.1)
Income (loss) from discontinued operations before income taxes	0.0		2.9	(34.5)	13.7
Income tax expense	9.4		0.8	35.2	1.3
Income (loss) from discontinued operations, net of tax	(9.4)		2.1	(69.7)	12.4
Gain (loss) from operations of discontinued component	(9.4)		2.1	(46.5)	12.4
Loss on disposal of discontinued operations	$ 0.0	$ (23.2)	$ 0.0	$ (23.2)	$ 0.0

DISCONTINUED OPERATIONS - Significant Classes of Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Total current assets	$ 0.0	$ 69.1
Current liabilities:
Total current liabilities	$ 0.0	52.5
Discontinued operations, disposed of by sale \| Enabling Services segment disposal
Current assets:
Cash and cash equivalents		0.0
Accounts receivable and unbilled services, net		60.4
Prepaid expenses and other		8.7
Total current assets		69.1
Property, plant and equipment, net		40.6
Goodwill, net		276.5
Intangible assets, net		43.1
Other assets, net		8.6
Total assets of discontinued operations		437.9
Current liabilities:
Accounts payable		4.5
Accrued expenses and other current liabilities		17.3
Unearned revenue		28.4
Short-term operating lease liabilities		2.3
Total current liabilities		52.5
Operating lease liabilities		3.7
Other liabilities		27.9
Total liabilities of discontinued operations		$ 84.1

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (267.3)	$ 29.3
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	66.1	73.6
Stock compensation	43.1	27.2
Credit loss expense	17.0	21.9
Operating lease right-of-use asset expense	10.8	20.9
Operating lease right-of-use asset impairment	4.8	0.0
Goodwill and other asset impairments	24.0	0.0
Deferred income taxes	(23.2)	(13.3)
Loss on sale of business	23.2	0.0
Write-off of debt issuance costs	12.2	0.0
Other, net	4.7	3.5
Changes in assets and liabilities:
Decrease (Increase) in accounts receivable and unbilled services, net	290.9	(45.0)
(Increase) decrease in prepaid expenses and other	(33.3)	0.6
Increase in accounts payable	5.8	45.9
Increase (decrease) in deferred revenue	106.4	(6.0)
Decrease in accrued expenses and other	(39.5)	(8.6)
Net cash provided by operating activities	245.7	150.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(28.7)	(30.9)
Proceeds from sale of business, net	276.6	0.0
Proceeds from sale of assets	0.2	8.1
Net cash provided by (used for) investing activities	248.1	(22.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities	617.0	24.0
Payments on revolving credit facilities	(617.0)	(24.0)
Proceeds from term loans	0.0	1,061.4
Proceeds from issuance of senior notes	0.0	570.0
Debt issuance costs	0.0	(26.4)
Principal payments of long-term debt	(482.7)	(7.7)
Payments for taxes related to net share settlement of stock awards	(14.0)	0.0
Special payment to Former Parent	0.0	1,595.0
Net transfers to Former Parent	0.0	(135.4)
Net cash used for financing activities	(496.7)	(133.1)
Effect of exchange rate changes on cash and cash equivalents	(0.4)	(0.7)
Net change in cash and cash equivalents	(3.3)	(6.6)
Cash and cash equivalents at beginning of period	108.6	110.4
Cash and cash equivalents at end of period	$ 105.3	$ 103.8

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS - Changes in Equity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			88.8	88.8			88.8
Beginning balance	$ 1,461.1	$ 1,591.9	$ 1,714.1	$ 1,747.8	$ 3,402.8	$ 3,340.0	$ 1,714.1	$ 3,340.0
Net income (loss)	(27.9)	(138.4)	(101.0)	(14.0)	30.8	12.5	(267.3)	29.3
Other comprehensive income (loss), net of tax	70.9	(7.4)	(26.1)	(54.4)	32.0	19.1	$ 37.4	(3.3)
Special payment to Former Parent					(1,595.0)
Net transfers from Former Parent					(122.9)	31.2
Net share settlement tax payments from issuance of stock to employees					0.0
Issuance of common stock					$ 0.1
Stock compensation	$ 13.0	15.0	15.1	11.1
Ending balance (in shares)	89.7				88.8		89.7
Ending balance	$ 1,513.5	$ 1,461.1	$ 1,591.9	$ 1,690.5	$ 1,747.8	$ 3,402.8	$ 1,513.5	$ 1,690.5
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	89.5	89.4	88.8	88.8	0.0	0.0	88.8	0.0
Beginning balance	$ 0.1	$ 0.1	$ 0.1	$ 0.1	$ 0.0	$ 0.0	$ 0.1	$ 0.0
Issuance of common stock (in shares)	0.2	0.1	0.6		88.8
Issuance of common stock					$ 0.1
Ending balance (in shares)	89.7	89.5	89.4	88.8	88.8	0.0	89.7	88.8
Ending balance	$ 0.1	$ 0.1	$ 0.1	$ 0.1	$ 0.1	$ 0.0	$ 0.1	$ 0.1
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	2,017.9	2,002.9	1,998.0	1,971.4	0.0	0.0	1,998.0	0.0
Net share settlement tax payments from issuance of stock to employees					1,971.4
Stock compensation	13.0	15.0	15.1	11.1
Ending balance	2,027.3	2,017.9	2,002.9	1,982.5	1,971.4	0.0	2,027.3	1,982.5
Former Parent Investment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	0.0	0.0	0.0	0.0	3,658.5	3,614.8	0.0	3,614.8
Net income (loss)					30.8	12.5
Special payment to Former Parent					(1,595.0)
Net transfers from Former Parent					(122.9)	31.2
Net share settlement tax payments from issuance of stock to employees					(1,971.4)
Ending balance	0.0	0.0	0.0	0.0	0.0	3,658.5	0.0	0.0
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(307.9)	(169.5)	(68.5)	0.0	0.0	0.0	(68.5)	0.0
Net income (loss)	(27.9)	(138.4)	(101.0)	(14.0)
Ending balance	(335.8)	(307.9)	(169.5)	(14.0)	0.0	0.0	(335.8)	(14.0)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(249.0)	(241.6)	(215.5)	(223.7)	(255.7)	(274.8)	(215.5)	(274.8)
Other comprehensive income (loss), net of tax	70.9	(7.4)	(26.1)	(54.4)	32.0	19.1
Ending balance	$ (178.1)	$ (249.0)	(241.6)	(278.1)	(223.7)	(255.7)	(178.1)	(278.1)
As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance			1,738.8	1,751.1	3,405.5	3,342.6	1,738.8	3,342.6
Net income (loss)				(13.1)	28.3	17.4		32.6
Other comprehensive income (loss), net of tax				(54.8)	31.6	18.9		(4.3)
Special payment to Former Parent					(1,595.0)
Net transfers from Former Parent					(119.4)	26.6
Net share settlement tax payments from issuance of stock to employees					0.0
Issuance of common stock					0.1
Stock compensation				11.1
Ending balance				$ 1,694.3	$ 1,751.1	$ 3,405.5		$ 1,694.3
As Previously Reported \| Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)				88.8	0.0	0.0		0.0
Beginning balance				$ 0.1	$ 0.0	$ 0.0		$ 0.0
Issuance of common stock (in shares)					88.8
Issuance of common stock					$ 0.1
Ending balance (in shares)				88.8	88.8	0.0		88.8
Ending balance				$ 0.1	$ 0.1	$ 0.0		$ 0.1
As Previously Reported \| Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				1,976.5	0.0	0.0		0.0
Net share settlement tax payments from issuance of stock to employees					1,976.5
Stock compensation				11.1
Ending balance				1,987.6	1,976.5	0.0		1,987.6
As Previously Reported \| Former Parent Investment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				0.0	3,662.6	3,618.6		3,618.6
Net income (loss)					28.3	17.4
Special payment to Former Parent					(1,595.0)
Net transfers from Former Parent					(119.4)	26.6
Net share settlement tax payments from issuance of stock to employees					(1,976.5)
Ending balance				0.0	0.0	3,662.6		0.0
As Previously Reported \| Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				0.0	0.0	0.0		0.0
Net income (loss)				(13.1)
Ending balance				(13.1)	0.0	0.0		(13.1)
As Previously Reported \| Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				(225.5)	(257.1)	(276.0)		(276.0)
Other comprehensive income (loss), net of tax				(54.8)	31.6	18.9
Ending balance				(280.3)	(225.5)	(257.1)		(280.3)
Adjustments
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance			$ (24.7)	(3.3)	(2.7)	(2.6)	$ (24.7)	(2.6)
Net income (loss)				(0.9)	2.5	(4.9)		(3.3)
Other comprehensive income (loss), net of tax				0.4	0.4	0.2		1.0
Net transfers from Former Parent					(3.5)	4.6
Net share settlement tax payments from issuance of stock to employees					0.0
Ending balance				$ (3.8)	$ (3.3)	$ (2.7)		$ (3.8)
Adjustments \| Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)				0.0	0.0	0.0		0.0
Beginning balance				$ 0.0	$ 0.0	$ 0.0		$ 0.0
Ending balance (in shares)				0.0	0.0	0.0		0.0
Ending balance				$ 0.0	$ 0.0	$ 0.0		$ 0.0
Adjustments \| Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				(5.1)	0.0	0.0		0.0
Net share settlement tax payments from issuance of stock to employees					(5.1)
Ending balance				(5.1)	(5.1)	0.0		(5.1)
Adjustments \| Former Parent Investment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				0.0	(4.1)	(3.8)		(3.8)
Net income (loss)					2.5	(4.9)
Net transfers from Former Parent					(3.5)	4.6
Net share settlement tax payments from issuance of stock to employees					5.1
Ending balance				0.0	0.0	(4.1)		0.0
Adjustments \| Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				0.0	0.0	0.0		0.0
Net income (loss)				(0.9)
Ending balance				(0.9)	0.0	0.0		(0.9)
Adjustments \| Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				1.8	1.4	1.2		1.2
Other comprehensive income (loss), net of tax				0.4	0.4	0.2
Ending balance				$ 2.2	$ 1.8	$ 1.4		$ 2.2

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
INCOME TAXES (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	48.30%	26.50%	1.20%	30.20%
Income tax (benefit) expense	$ (17.3)	$ (5.8)	$ (2.5)	$ 7.3
Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent	14.80%
Unrecognized tax benefits, increase			$ 0.1

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (a)
-SubTopic 20
-Topic 740
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-SubTopic 10
-Topic 235
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 105.3			$ 108.6
Accounts receivable and unbilled services, net	689.1			988.5
Prepaid expenses and other	142.5			84.6
Current assets of discontinued operations	0.0			69.1
Total current assets	936.9			1,250.8
Property, plant and equipment, net	173.1			172.6
Goodwill, net	1,767.0			1,739.4
Intangible assets, net	691.2			728.1
Deferred income taxes	3.2			3.2
Other assets, net	92.3			69.7
Long-term assets of discontinued operations	0.0			368.8
Total assets	3,663.7			4,332.6
Current liabilities:
Accounts payable	137.6			132.9
Accrued expenses and other current liabilities	323.1			335.5
Unearned revenue	321.1			214.2
Current portion of long-term debt	0.0			26.1
Short-term operating lease liabilities	14.0			17.2
Current liabilities of discontinued operations	0.0			52.5
Total current liabilities	795.8			778.4
Long-term debt, less current portion	1,124.5			1,565.9
Operating lease liabilities	65.4			62.8
Deferred income taxes and other tax liabilities	126.9			147.7
Other liabilities	37.6			32.1
Long-term liabilities of discontinued operations	0.0			31.6
Total liabilities	2,150.2			2,618.5
Commitments and contingent liabilities
Equity
Former parent investment				0.0
Common stock	0.1			0.1
Additional paid-in capital	2,027.3			1,998.0
Accumulated deficit	(335.8)			(68.5)
Accumulated other comprehensive loss	(178.1)			(215.5)
Total equity	1,513.5	$ 1,461.1	$ 1,591.9	1,714.1	$ 1,690.5	$ 1,747.8	$ 3,402.8	$ 3,340.0
Total liabilities and equity	$ 3,663.7			4,332.6
As Previously Reported
Current assets:
Cash and cash equivalents				108.6
Accounts receivable and unbilled services, net				1,052.1
Prepaid expenses and other				92.4
Current assets of discontinued operations				0.0
Total current assets				1,253.1
Property, plant and equipment, net				220.9
Goodwill, net				2,029.3
Intangible assets, net				771.2
Deferred income taxes				3.2
Other assets, net				79.5
Long-term assets of discontinued operations				0.0
Total assets				4,357.2
Current liabilities:
Accounts payable				132.8
Accrued expenses and other current liabilities				356.1
Unearned revenue				241.4
Current portion of long-term debt				26.1
Short-term operating lease liabilities				19.5
Current liabilities of discontinued operations				0.0
Total current liabilities				775.9
Long-term debt, less current portion				1,565.9
Operating lease liabilities				66.5
Deferred income taxes and other tax liabilities				148.8
Other liabilities				61.3
Long-term liabilities of discontinued operations				0.0
Total liabilities				2,618.4
Commitments and contingent liabilities
Equity
Former parent investment				0.0
Common stock				0.1
Additional paid-in capital				2,006.2
Accumulated deficit				(49.1)
Accumulated other comprehensive loss				(218.4)
Total equity				1,738.8	1,694.3	1,751.1	3,405.5	3,342.6
Total liabilities and equity				4,357.2
Adjustments
Current assets:
Cash and cash equivalents				0.0
Accounts receivable and unbilled services, net				(3.2)
Prepaid expenses and other				0.9
Current assets of discontinued operations				0.0
Total current assets				(2.3)
Property, plant and equipment, net				(7.7)
Goodwill, net				(13.4)
Intangible assets, net				0.0
Deferred income taxes				0.0
Other assets, net				(1.2)
Long-term assets of discontinued operations				0.0
Total assets				(24.6)
Current liabilities:
Accounts payable				4.6
Accrued expenses and other current liabilities				(3.3)
Unearned revenue				1.2
Current portion of long-term debt				0.0
Short-term operating lease liabilities				0.0
Current liabilities of discontinued operations				0.0
Total current liabilities				2.5
Long-term debt, less current portion				0.0
Operating lease liabilities				0.0
Deferred income taxes and other tax liabilities				(1.1)
Other liabilities				(1.3)
Long-term liabilities of discontinued operations				0.0
Total liabilities				0.1
Commitments and contingent liabilities
Equity
Former parent investment				0.0
Common stock				0.0
Additional paid-in capital				(8.2)
Accumulated deficit				(19.4)
Accumulated other comprehensive loss				2.9
Total equity				(24.7)	$ (3.8)	$ (3.3)	$ (2.7)	$ (2.6)
Total liabilities and equity				(24.6)
As Restated
Current assets:
Cash and cash equivalents				108.6
Accounts receivable and unbilled services, net				1,048.9
Prepaid expenses and other				93.3
Current assets of discontinued operations				0.0
Total current assets				1,250.8
Property, plant and equipment, net				213.2
Goodwill, net				2,015.9
Intangible assets, net				771.2
Deferred income taxes				3.2
Other assets, net				78.3
Long-term assets of discontinued operations				0.0
Total assets				4,332.6
Current liabilities:
Accounts payable				137.4
Accrued expenses and other current liabilities				352.8
Unearned revenue				242.6
Current portion of long-term debt				26.1
Short-term operating lease liabilities				19.5
Current liabilities of discontinued operations				0.0
Total current liabilities				778.4
Long-term debt, less current portion				1,565.9
Operating lease liabilities				66.5
Deferred income taxes and other tax liabilities				147.7
Other liabilities				60.0
Long-term liabilities of discontinued operations				0.0
Total liabilities				2,618.5
Commitments and contingent liabilities
Equity
Former parent investment				0.0
Common stock				0.1
Additional paid-in capital				1,998.0
Accumulated deficit				(68.5)
Accumulated other comprehensive loss				(215.5)
Total equity				1,714.1
Total liabilities and equity				4,332.6
Reclassifications \| Discontinued Operations Reclassifications
Current assets:
Cash and cash equivalents				0.0
Accounts receivable and unbilled services, net				(60.4)
Prepaid expenses and other				(8.7)
Current assets of discontinued operations				69.1
Total current assets				0.0
Property, plant and equipment, net				(40.6)
Goodwill, net				(276.5)
Intangible assets, net				(43.1)
Deferred income taxes				0.0
Other assets, net				(8.6)
Long-term assets of discontinued operations				368.8
Total assets				0.0
Current liabilities:
Accounts payable				(4.5)
Accrued expenses and other current liabilities				(17.3)
Unearned revenue				(28.4)
Current portion of long-term debt				0.0
Short-term operating lease liabilities				(2.3)
Current liabilities of discontinued operations				52.5
Total current liabilities				0.0
Long-term debt, less current portion				0.0
Operating lease liabilities				(3.7)
Deferred income taxes and other tax liabilities				0.0
Other liabilities				(27.9)
Long-term liabilities of discontinued operations				31.6
Total liabilities				0.0
Commitments and contingent liabilities
Equity
Former parent investment				0.0
Common stock				0.0
Additional paid-in capital				0.0
Accumulated deficit				0.0
Accumulated other comprehensive loss				0.0
Total equity				0.0
Total liabilities and equity				$ 0.0

BASIS OF FINANCIAL STATEMENT PREPARATION (Policies)	9 Months Ended
BASIS OF FINANCIAL STATEMENT PREPARATION (Policies)	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reportable Segment	Reportable Segment On March 9, 2024, the Company, together with its wholly-owned subsidiary, Fortrea Inc., entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Endeavor Buyer LLC, an affiliate of Arsenal Capital Partners, to sell the operations of Fortrea Patient Access Inc. and its subsidiaries and Endpoint Clinical, Inc. and its subsidiaries; which are all collectively referred to as the Enabling Services Segment. Refer to Note 2 - Discontinued Operations for further discussion. For all periods presented, the Company's consolidated revenues from continuing operations were generated from the Clinical Services segment, which provides phase I-IV clinical trials, including clinical pharmacology and comprehensive clinical development capabilities. The Company’s chief operating decision maker allocates resources and assesses performance for the Clinical Services segment.
Discontinued Operations	Discontinued Operations In accordance with the definition of discontinued operations, the Company's decision to sell the assets relating to the Enabling Services Segment represented a strategic shift that had a major effect on the Company's results of operations and assets and liabilities for the periods presented. As a result, the Company has classified the assets and liabilities related to the Enabling Services Segment as assets of discontinued operations and liabilities of discontinued operations on the condensed consolidated balance sheet as of December 31, 2023. The operations of the Enabling Services Segment have been classified as income (loss) from discontinued operations on the condensed consolidated and combined statements of operations for all periods presented. Unless otherwise noted, discussion within these notes to the condensed consolidated and combined financial statements relates to the Company’s continuing operations.
Basis of Financial Statement Presentation	Basis of Financial Statement Presentation Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company, and reflect Labcorp’s net investment in the Company. The condensed consolidated financial statements subsequent to June 30, 2023 reflect the results of operations, cash flows, and financial position of Fortrea as a standalone company, whereas all prior periods included consolidated and combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.” The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year, and additionally, condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The condensed consolidated and combined statements of operations include all revenues and costs directly attributable to Fortrea’s business. The combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation. These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or another reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented and may not be representative of future expenses that may be incurred. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp. As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent. All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services. The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions. Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2024, one customer accounted for 15.6% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2023, two pharmaceutical companies accounted for approximately 17.0% and 11.2% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months ended September 30, 2024, one customer accounted for approximately 15.1% of revenues, and for the nine months ended September 30, 2024, two customers accounted for approximately 14.2% and 10.4% of revenues. For the three months ended September 30, 2023, two customer accounted for 14.6% and 11.4% of revenues, and for the nine months ended September 30, 2023, two customer accounted for 11.1% and 10.6% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.
Reclassification	Reclassification Certain previously reported amounts have been reclassified to conform to the current year presentation. During the quarter ended March 31, 2024, a change in basis of presentation, to include information technology costs and certain facility costs in Selling, general and administrative expenses was made to improve comparability of costs against peer companies in the clinical research industry. As a result, the Company reclassified $39.0 and $117.3 from Direct costs, exclusive of depreciation and amortization, to Selling, general and administrative expenses, exclusive of depreciation and amortization in the condensed consolidated and combined statement of operations for the three and nine months ended September 30, 2023, respectively, relating to information technology costs and certain facility charges. There is no impact on total operating expenses, operating income or net income during the period ended September 30, 2023. Direct costs include payroll and related benefits for project-related employees, pass through costs, facility costs related to phase I clinics and other direct costs from the Transition Services Agreement with Labcorp. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, information technology costs, other facility charges, advertising and promotional expenses, administrative travel and credit loss provisions.
Recently Issued and Adopted Accounting Standards	Recently Issued and Adopted Accounting Standards In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to improve reportable segment disclosure requirements. The new guidance requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included in the reported measure of segment profit or loss. It does not change the definition of a segment or the guidance for determining reportable segments. The new guidance will be effective for the Company in the annual period beginning January 1, 2024 and in 2025 for interim periods. The Company does not expect the adoption of this standard to have a material impact on its results of operations, financial position or cash flows. In December 2023, the FASB issued guidance to require qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

- Definition

Disclosure of accounting policy for segment reporting.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 36
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-36

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-29

+ Details

IMMATERIAL FINANCIAL RESTATEMENT AND RECLASSIFICATIONS TO PRIOR PERIOD FINANCIAL STATEMENTS - Statements of Cash Flow (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (27.9)	$ (138.4)	$ (101.0)	$ (14.0)	$ 30.8	$ 12.5	$ (267.3)	$ 29.3
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization							66.1	73.6
Stock compensation							43.1	27.2
Operating lease right-of-use asset expense							10.8	20.9
Goodwill and other asset impairments								0.0
Deferred income taxes							(23.2)	(13.3)
Other, net							4.7	3.5
Changes in assets and liabilities:
Increase in accounts receivable and unbilled services, net								(23.1)
Decrease in prepaid expenses and other							(33.3)	0.6
Increase in accounts payable							5.8	45.9
Increase (decrease) in deferred revenue							106.4	(6.0)
Decrease in accrued expenses and other							(39.5)	(8.6)
Net cash provided by operating activities							245.7	150.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures							(28.7)	(30.9)
Proceeds from sale of assets							0.2	8.1
Net cash provided by (used for) investing activities							248.1	(22.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities							617.0	24.0
Payments on revolving credit facilities							(617.0)	(24.0)
Proceeds from term loans							0.0	1,061.4
Proceeds from issuance of senior notes							0.0	570.0
Debt issuance costs							0.0	(26.4)
Principal payments of long-term debt							(482.7)	(7.7)
Special payment to Former Parent							0.0	(1,595.0)
Net transfers to Former Parent							0.0	(135.4)
Net cash used for financing activities							(496.7)	(133.1)
Effect of exchange rate changes on cash and cash equivalents							(0.4)	(0.7)
Net change in cash and cash equivalents							(3.3)	(6.6)
Cash and cash equivalents at beginning of period			$ 108.6			110.4	108.6	110.4
Cash and cash equivalents at end of period	$ 105.3			103.8			$ 105.3	103.8
As Previously Reported
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)				(13.1)	28.3	17.4		32.6
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization								72.5
Stock compensation								27.2
Operating lease right-of-use asset expense								20.9
Goodwill and other asset impairments								0.0
Deferred income taxes								(12.7)
Other, net								3.5
Changes in assets and liabilities:
Increase in accounts receivable and unbilled services, net								(26.6)
Decrease in prepaid expenses and other								(3.1)
Increase in accounts payable								47.3
Increase (decrease) in deferred revenue								(6.5)
Decrease in accrued expenses and other								(0.1)
Net cash provided by operating activities								155.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures								(30.9)
Proceeds from sale of assets								8.1
Net cash provided by (used for) investing activities								(22.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities								24.0
Payments on revolving credit facilities								(24.0)
Proceeds from term loans								1,061.4
Proceeds from issuance of senior notes								570.0
Debt issuance costs								(26.4)
Principal payments of long-term debt								(7.7)
Special payment to Former Parent								(1,595.0)
Net transfers to Former Parent								(136.7)
Net cash used for financing activities								(134.4)
Effect of exchange rate changes on cash and cash equivalents								(2.3)
Net change in cash and cash equivalents								(4.5)
Cash and cash equivalents at beginning of period						112.0		112.0
Cash and cash equivalents at end of period				107.5				107.5
Adjustments
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)				(0.9)	$ 2.5	(4.9)		(3.3)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization								1.1
Stock compensation								0.0
Operating lease right-of-use asset expense								0.0
Goodwill and other asset impairments								0.0
Deferred income taxes								(0.6)
Other, net								0.0
Changes in assets and liabilities:
Increase in accounts receivable and unbilled services, net								3.5
Decrease in prepaid expenses and other								3.7
Increase in accounts payable								(1.4)
Increase (decrease) in deferred revenue								0.5
Decrease in accrued expenses and other								(8.5)
Net cash provided by operating activities								(5.0)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures								0.0
Proceeds from sale of assets								0.0
Net cash provided by (used for) investing activities								0.0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities								0.0
Payments on revolving credit facilities								0.0
Proceeds from term loans								0.0
Proceeds from issuance of senior notes								0.0
Debt issuance costs								0.0
Principal payments of long-term debt								0.0
Special payment to Former Parent								0.0
Net transfers to Former Parent								1.3
Net cash used for financing activities								1.3
Effect of exchange rate changes on cash and cash equivalents								1.6
Net change in cash and cash equivalents								(2.1)
Cash and cash equivalents at beginning of period						$ (1.6)		(1.6)
Cash and cash equivalents at end of period				$ (3.7)				$ (3.7)

STOCK COMPENSATION PLANS

9 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

STOCK COMPENSATION PLANS

The Company granted 0.1 and 1.1 restricted stock units during the three and nine months ended September 30, 2024, respectively, with a weighted average grant date fair value of $21.39 and $37.62 per share.

Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Direct costs	$	11.2	$	6.6	$	32.5	$	15.4
Selling, general and administrative expenses	1.8		3.8		9.4		10.1
Total stock compensation expense	$	13.0	$	10.4	$	41.9	$	25.5

Income tax benefits	$	2.1	$	1.7	$	6.4	$	4.4

EARNINGS (LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Reconciliation of Basic Earnings per Share to Diluted Earnings per Share

The following represents a reconciliation of basic earnings (loss) per share to diluted earnings (loss) from continuing operations per share.


	Three Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from continuing operations per share:
Net earnings (loss)	$	(18.5)	89.6	$	(0.21)	$	(16.1)	88.8	$	(0.18)
Dilutive effect of employee stock options and awards	—		—	—		—		—	—
Net earnings (loss) from continuing operations including impact of dilutive adjustments	$	(18.5)	89.6	$	(0.21)	$	(16.1)	88.8	$	(0.18)


	Nine Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from continuing operations per share:
Net earnings (loss)	$	(197.6)	89.4	$	(2.21)	$	16.9	88.8	$	0.19
Dilutive effect of employee stock options and awards	—		—	—		—		0.2	—
Net earnings (loss) from continuing operations including impact of dilutive adjustments	$	(197.6)	89.4	$	(2.21)	$	16.9	89.0	$	0.19

The following represents a reconciliation of basic earnings (loss) per share to diluted earnings (loss) from discontinued operations per share.


	Three Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from discontinued operations per share:
Net earnings (loss)	$	(9.4)	89.6	$	(0.10)	$	2.1	88.8	$	0.02
Dilutive effect of employee stock options and awards	—		—	—		—		—	—
Net earnings (loss) from discontinued operations including impact of dilutive adjustments	$	(9.4)	89.6	$	(0.10)	$	2.1	88.8	$	0.02


	Nine Months Ended September 30,
	2024					2023
	Earnings		Shares	Per Share Amount		Earnings		Shares	Per Share Amount
Basic earnings (loss) from discontinued operations per share:
Net earnings (loss)	$	(69.7)	89.4	$	(0.78)	$	12.4	88.8	$	0.14
Dilutive effect of employee stock options and awards	—		—	—		—		0.2	—
Net earnings (loss) from discontinued operations including impact of dilutive adjustments	$	(69.7)	89.4	$	(0.78)	$	12.4	89.0	$	0.14

Schedule of Antidilutive Securities Excluded from Computation

The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Employee stock options and awards	2.8	0.5	2.0	1.5
Antidilutive employee stock options and awards excluded based on reporting a net loss for the period	0.5	0.4	0.9	—

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Costs incurred from related parties	$ 1,674.0
Related party
Costs incurred from related parties	$ 48.8

DISCONTINUED OPERATIONS

9 Months Ended

Sep. 30, 2024

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

On March 9, 2024, the Company entered into the Purchase Agreement with Endeavor Buyer LLC, an affiliate of Arsenal Capital Partners, pursuant to which Fortrea Inc. agreed to sell, and to cause its affiliates to sell, net assets relating to its Enabling Services Segment (the “Transaction”), specifically its Patient Access and Endpoint businesses, including the sale of equity interests of Fortrea Patient Access Inc. and its subsidiaries and Endpoint Clinical, Inc. and its subsidiaries. The final adjusted purchase price for the Transaction was $340.0, subject to customary purchase price adjustments, with $295.0 paid at closing and $45.0 to be paid upon achievement of certain transition-related milestones. The Transaction closed during the second quarter of 2024 with estimated proceeds of

$281.6 and resulting in a loss on disposal of $23.2, subject to further adjustment based on customary purchase price adjustments.

Financial Information of Discontinued Operations


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Revenues	$	—	$	63.4	$	106.4	$	198.0
Costs and expenses:
Direct costs, exclusive of depreciation and amortization	—		44.8		66.4		135.2
Selling, general and administrative expenses, exclusive of depreciation and amortization	—		12.1		25.4		39.9
Depreciation and amortization	—		2.2		1.6		6.5
Long-lived and goodwill asset impairments	—		—		24.0		—
Restructuring and other charges	—		1.5		0.5		2.4
Total costs and expenses	—		60.6		117.9		184.0
Operating income (loss)	—		2.8		(11.5)		14.0
Other expense:

Foreign exchange gain (loss)	—		0.1		0.1		(0.2)
Loss on sale of a business	—		—		(23.2)		—
Other, net	—		—		0.1		(0.1)
Income (loss) from discontinued operations before income taxes	—		2.9		(34.5)		13.7
Income tax expense	9.4		0.8		35.2		1.3
Income (loss) from discontinued operations, net of tax	$	(9.4)	$	2.1	$	(69.7)	$	12.4


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Gain (loss) from operations of discontinued component	$	(9.4)	$	2.1	$	(46.5)	$	12.4
Loss on disposal of discontinued operations	—		—		(23.2)		—
Gain (loss) on discontinued operations	$	(9.4)	$	2.1	$	(69.7)	$	12.4

In the first quarter of 2024, as a result of the negotiated sale price of the Patient Access and Endpoint businesses, the Company evaluated the Enabling Services Segment for impairment and determined that it was more likely than not that the carrying value of the assets exceeded its fair value. Accordingly, an impairment analysis was performed, which resulted in a goodwill impairment charge of $24.0.

The following table summarizes the carrying value of the significant classes of assets and liabilities classified as discontinued operations as of December 31, 2023:


	December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	—
Accounts receivable and unbilled services, net	60.4
Prepaid expenses and other	8.7
Total current assets	69.1
Property, plant and equipment, net	40.6
Goodwill, net	276.5
Intangible assets, net	43.1

Other assets, net	8.6
Total assets of discontinued operations	$	437.9
LIABILITIES
Current liabilities:
Accounts payable	$	4.5
Accrued expenses and other current liabilities	17.3
Unearned revenue	28.4
Short-term operating lease liabilities	2.3
Total current liabilities	52.5
Operating lease liabilities	3.7

Other liabilities	27.9
Total liabilities of discontinued operations	$	84.1

The cash flows related to discontinued operations have not been segregated and are included in the condensed consolidated and combined statements of cash flows. The following table summarizes depreciation and amortization, capital expenditures and the significant cash flow and noncash items from discontinued operations for the nine months ended September 30, 2024 and 2023:


	Nine months ended September 30,
	2024		2023
Depreciation and amortization	$	1.6	$	6.5
Goodwill impairment	24.0		—
Loss on sale of business	23.2		—
Capital expenditures	7.4		12.0

There are no significant operating or investing noncash items related to discontinued operations for the nine months ended September 30, 2024 and 2023.

PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY

PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY

The Company is authorized to issue up to 265.0 shares of common stock, par value $0.001 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.001 per share. There were no preferred shares outstanding as of September 30, 2024 and December 31, 2023.

Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) are as follows:


	Foreign Currency Translation Adjustments		Net Benefit Plan Adjustments		Unrealized Gain (Loss) on Derivative Instruments		Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2023	$	(206.7)	$	(7.4)	$	(1.4)	$	(215.5)
Current quarter foreign exchange adjustments	(27.7)		—		—		(27.7)
Unrealized gain on derivative instrument	—		—		2.5		2.5
Amounts reclassified from other accumulated income (loss)	—		—		(0.4)		(0.4)
Tax effect of adjustments	—		—		(0.5)		(0.5)
Balance at March 31, 2024	(234.4)		(7.4)		0.2		(241.6)
Current quarter foreign exchange adjustments	(7.7)		—		—		(7.7)
Unrealized gain on derivative instrument	—		—		0.8		0.8
Amounts reclassified from other accumulated income (loss)	—		—		(0.4)		(0.4)
Tax effect of adjustments	—		—		(0.1)		(0.1)
Balance at June 30, 2024	(242.1)		(7.4)		0.5		(249.0)
Current quarter foreign exchange adjustments	73.4		—		—		73.4
Unrealized gain on derivative instrument	—		—		(2.9)		(2.9)
Amounts reclassified from other accumulated income (loss)	—		—		(0.4)		(0.4)
Tax effect of adjustments	—		—		0.8		0.8
Balance at September 30, 2024	$	(168.7)	$	(7.4)	$	(2.0)	$	(178.1)


	Foreign Currency Translation Adjustments		Net Benefit Plan Adjustments		Unrealized Gain (Loss) on Derivative Instruments		Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022	$	(266.0)	$	(8.8)	$	—	$	(274.8)
Current quarter foreign exchange adjustments	19.1		—		—		19.1
Tax effect of adjustments	—		—		—		—
Balance at March 31, 2023	(246.9)		(8.8)		—		(255.7)
Current quarter foreign exchange adjustments	29.9		—		—		29.9
Net benefit plan adjustments	—		2.1		—		2.1
Tax effect of adjustments	—		—		—		—
Balance at June 30, 2023	(217.0)		(6.7)		—		(223.7)
Current quarter foreign exchange adjustments	(55.6)		—		—		(55.6)
Unrealized gain on derivative instrument	—		—		1.6		1.6
Tax effect of adjustments	—		—		(0.4)		(0.4)
Balance at September 30, 2023	$	(272.6)	$	(6.7)	$	1.2	$	(278.1)

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details

REVENUES

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

REVENUES

The Company’s revenues by geography for the three and nine months ended September 30, 2024 and 2023 are as follows:


	Three Months Ended September 30, 2024								Three Months Ended September 30, 2023
	North America		Europe		Other		Total		North America		Europe		Other		Total
Revenues	$	319.7	$	191.8	$	163.4	$	674.9	$	349.5	$	204.3	$	160.0	$	713.8


	Nine Months Ended September 30, 2024								Nine Months Ended September 30, 2023
	North America		Europe		Other		Total		North America		Europe		Other		Total
Revenues	$	944.4	$	595.1	$	459.9	$	1,999.4	$	1,073.6	$	600.7	$	458.5	$	2,132.8

Revenue from the United States comprises substantially all revenue in North America.

Contract Costs

The following table provides information about contract asset balances:


	September 30, 2024		December 31, 2023
Sales commission assets	$	20.6	$	15.8
Deferred contract costs	1.4		2.0
Total	$	22.0	$	17.8

Amortization related to sales commission assets for the three months ended September 30, 2024 and 2023 was $2.9 and $2.0, respectively, and for the nine months ended September 30, 2024 and 2023 was $8.5 and $9.4, respectively. Amortization related to deferred contract costs for the three months ended September 30, 2024 and 2023 was $0.6 and $0.5, respectively, and for the nine months ended September 30, 2024 and 2023 was $1.5 and $1.6, respectively. The Company applies the practical expedient to not recognize the effect of financing in its contracts with customers when the difference in timing of payment and performance is one year or less.

Accounts Receivable, Unbilled Services and Unearned Revenue

The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:


	September 30, 2024		December 31, 2023
Accounts receivable	$	156.2	$	420.2
Unbilled services	569.9		600.0
Less: allowance for credit losses	(37.0)		(31.7)
Total	$	689.1	$	988.5

Unearned revenue	$	321.1	$	214.2

Revenue recognized during the period that was included in the unearned revenue balance at the beginning of the period was $147.6 and $162.6 for the nine months ended September 30, 2024 and 2023, respectively. Additionally, as of the quarter ended September 30, 2024, the Company had sold $300.0 of receivables as described in the Receivables Securitization Program section below.

Credit Loss Rollforward

The Company estimates future expected losses on accounts receivable and unbilled services over the remaining collection period of the instrument.

The rollforward for the allowance for credit losses for the nine months ended September 30, 2024 is as follows:


	Accounts Receivable
Allowance for credit losses as of December, 2023	$	31.7
Credit loss expense	17.0
Write-offs	(11.6)
Foreign currency impact	(0.1)
Allowance for credit losses as of September 30, 2024	$	37.0

Performance Obligations Under Long-Term Contracts

As of September 30, 2024, approximately $4,491 of revenues are expected to be recognized from remaining long-term performance obligations. The Company expects to recognize approximately 27% of the existing performance obligations as of September 30, 2024 as revenue over the next 12 months and the remaining balance thereafter. The Company’s long-term contracts generally range from one to eight years.

During the three and nine months ended September 30, 2024, there were reductions of approximately $6 and $58, respectively, in revenue related to performance obligations partially satisfied in previous periods. For the three months ended September 30, 2024, the majority of the change was associated with changes in estimated effort to complete customer contract obligations and a smaller portion related to changes in scope or price. For the three months ended September 30, 2024, the change in estimate resulted in an estimated reduction to revenue of $4, and an increase in loss from continuing operations of $2 and in loss per share of $0.02. For the nine months ended September 30, 2024, the change in estimate resulted in an estimated reduction to revenue of $25, and an increase in loss from continuing operations of $25 and in loss per share of $0.28.

During the three and nine months ended September 30, 2023, there were reductions of approximately $16 and $48, respectively, in revenue related to performance obligations partially satisfied in previous periods. For the three months ended September 30, 2023, the majority of the change was associated with changes in scope and price and a smaller portion related to changes in estimated effort to complete customer contract obligations. For the three months ended September 30, 2023, the change in estimate resulted in an estimated reduction to revenue of $5, and an increase in loss from continuing operations of $4 and in loss per share of $0.05. For the nine months ended September 30, 2023, the change in estimate resulted in an estimated reduction to revenue of $21, and a decrease in income from continuing operations of $14 and in income per share of $0.16.

Accounts Receivable Purchase Program

On June 23, 2023, Fortrea entered into an accounts receivable purchase program (“ARPP”) with a financial institution (the “Financial Institution”). The ARPP established a receivables factoring facility whereby the Company could sell up to $80.0 in customer receivables based on the availability of certain eligible receivables and the satisfaction of certain conditions. Under the facility, the Company could sell eligible receivables and retain no interest in the transferred receivables other than collection and administrative functions for the Financial Institution.

The Company accounted for these receivable transfers as sales and derecognized the sold receivables from its balance sheets. The fair value of the sold receivables approximated their book value due to their short-term nature. The Company continued to service, administer and collect the receivables on behalf of the Financial Institution and did not receive a servicing fee as part of the arrangement. On June 28, 2023, $17.5 of receivables were sold with net proceeds of $17.3. The ARPP was terminated in May 2024, and there were no receivables outstanding as of the date of termination.

Receivables Securitization Program

On May 6, 2024, the Company entered into a three-year $300.0 accounts receivable securitization program (the “Receivables Facility”). Under this program, Fortrea Inc. conveys receivable balances to a wholly-owned, bankruptcy-remote special purpose entity (“SPE”), who in turn, may sell receivables to a third-party financial institution in exchange for cash. The facility is without recourse to the Company or any subsidiaries of the Company, other than with respect to limited indemnity obligations of Fortrea Inc., in respect to the character of the receivables sold and as to the performance of its duties as servicer and a limited performance guaranty by the Company. All unsold accounts receivables held by the SPE are pledged as collateral to secure the collectability of the sold receivables. The Receivables Facility is scheduled to terminate on May 6, 2027, unless terminated earlier pursuant to its terms.

As of September 30, 2024, the Company had sold $300.0 of receivables, which were derecognized from the Company’s consolidated balance sheet, with net proceeds of $297.9, as described in the Accounts Receivable, Unbilled Services and Unearned Revenue section above. Total costs associated with the sale were $5.3 and $7.4 for the three and nine months ended September 30, 2024, respectively, and are included within Selling, general and administrative costs, exclusive of depreciation and amortization in the condensed consolidated and combined statement of operations for the three and nine months ended September 30, 2024. Continuous cash activity related to the Receivables Facility is reflected in cash from operating activities in the consolidated statement of cash flows.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details